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 N-Heterocyclic carbenes (NHCs) are ubiquitous organocatalysts in a variety of asymmetric 
transformations. The benzoin and Stetter reactions, which couple aldehydes to other aldehydes or 
Michael acceptors, respectively are the most commonly reported reactivity manifold employing 
NHC catalysts. However, other umpolung reactivity pathways exist, for example, when α,β-
unsaturated aldehydes are reacted with NHCs, the Breslow intermediate can react through the 
double bond of the aldehyde to functionalize at the beta position of the carbonyl. A process that 
has come to be known has homoenolate reactivity. 
 A range of reactivity manifolds were investigated, including the asymmetric intermolecular 
Stetter reaction and an enantioselective NHC-catalyzed nucleophilic dearomatization of 
pyridiniums. In the dearomatization chemistry, a homoenolate equivalent is first generated from 
an enal and an NHC, which then adds to the pyridinium to generate 1,4-dihydropyridines with high 
enantioselectivity. This is a rare example of catalytic, asymmetric addition of a nucleophile to the 
activated pyridinium that prefers C-4 functionalization leading to the 1,4-dihydropyridine product. 
 The asymmetric intermolecular Stetter reaction was also investigated in an attempt to 
broaden the scope of the reaction to include less activated Michael acceptors, specifically, α,β-
unsaturated ketones. The coupling of heteroaryl aldehydes to enones could be achieved with 
appreciable levels of enantioselectivity (up to 80% ee), but reactivity remains a major challenge 
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Although N-Heterocyclic carbenes had been used for benzoin reactions as early as the 
1940’s, broad interest in their reactivity and chemical properties was not generated until 
independent reports of stable carbenes by Bertrand1 and Arduengo.2 Since these initial reports, N-
heterocyclic carbenes (NHCs) have impacted many fields of organic chemistry including 
organocatalysis,3,4 transition metal catalysis,5 and polymer chemistry.6 Thiazolium-derived NHC 
scaffolds were initially popular because of their similarity to Thiamine. However, high 
enantioselectivity could not be achieved with these catalysts and triazolium-based N-heterocyclic 
carbene (NHC) precursors were developed. Since the introduction of triazolium scaffolds for 
catalysis, many reports have appeared demonstrating reliably high enantioselectivity across a 
range of different NHC-catalyzed reactions can be achieved. The high activity and selectivity 
across such varying reactivity, powered, the need for fine-tuning the NHC structure and has led to 
an impressive number of reported carbene-catalysts.  
1.1 Umpolung Acyl Anion Catalysis 
The most studied umpolung reaction employing NHC organocatalysts is the benzoin 
reaction. This was first discovered by Wöhler and Liebig in 1832 using cyanide as the catalyst to 
couple benzaldehyde to form benzoin.7 The currently accepted mechanism of this transformation 
was first proposed by Lapworth8 and is shown in scheme 1.1.1 First, cyanide adds to benzaldehyde 
generating tetrahedral intermediate 1, which then undergoes a proton transfer to give intermediate 
2. This intermediate where the anionic charge is localized on the carbon of the aldehyde is 
responsible for the umpolung reactivity observed in this reaction. Carbanion 2 then adds to another 
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equivalent of aldehyde to give intermediate 3, which, after proton transfer, collapses to generate 
the observed benzoin product (4) and the cyanide catalyst. 
 
Scheme 1.1.1  
In 1943, Ukai demonstrated the same reaction could be carried out with catalytic amounts 
of thiazolium in the presence of base.9 Inspired by the Lapworth mechanism, Breslow proposed a 
similar pathway for the thiazolium catalyzed benzoin reaction while investigating the mechanism 
of thiamine action.10 Breslow’s key insight was that the thiazolium could be deprotonated a the 2-
position to generate an ylide where the carbanion acts as the reactive center of the catalyst. This 
hypothesis was supported by deuterium exchange experiments with thiamine in D2O. After this 
finding, it was reasoned that the deprotonated thiazolium bearing a carbanion at the C-2 position 
could react similarly to the cyanide ion and catalyze benzoin formation.  
The currently accepted mechanism for the thiazolium-catalyzed benzoin reaction is shown 
in scheme 1.1.2. The thiazolium is first deprotonated to give an ylide (a resonance form of the free 
carbene), which then adds to an aldehyde generating tetrahedral intermediate 5. This then 
undergoes proton transfer, to give carbanion 6, which is in resonance with neutral enaminol 7, 
commonly referred to as the Breslow intermediate. Addition of 6 to another equivalent of aldehyde 
gives tetrahedral intermediate 8, followed by proton transfer and collapse to form 4 and regenerate 
the active catalyst. In-depth kinetic studies were later performed on the mechanism of the benzoin 
reaction by White and Leeper.11 The authors determined the three kinetically significant steps were 
initial addition of the NHC to the aldehyde, tautomerization to form the Breslow intermediate, and 
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addition of this intermediate to another equivalent of benzaldehyde. Interestingly, all three steps 
contributed to the rate of the reaction and were partially rate-limiting. 
 
Scheme 1.1.2 
The Breslow intermediate generated upon addition of the carbene to an aldehyde was later 
demonstrated to couple aldehydes with other electrophiles, such as Michael acceptors. This 
reactivity was heavily investigated by Stetter in the 1970’s and has since become known as the 
Stetter reaction.12 Due to its importance in NHC catalysis, much work has been devoted to the 
isolation and characterization of the Breslow intermediate.13 Berkessel isolated and characterized 
the Breslow intermediate derived from imidazolinium-derived NHCs and aryl aldehydes.14 
Through competition experiments with these isolated intermediates, he demonstrated the 




1.2 Asymmetric Benzoin Reactions 
The benzoin reaction has been widely studied and has become a benchmark reaction to test 
new carbene scaffolds. Sheehan reported an asymmetric variant of the reaction in 1966 using a 
chiral thiazolium that gave the benzoin product in 22% ee.15 Since this time, many groups have 
sought to improve the efficiency of the reaction by designing catalysts to increase the yield and 
enantioselectivity of the process.16 Figure 1.2.1 illustrates the major advances during the evolution 
of catalyst design that took place over 50 years and allowed for high enantioselectivity to be 
achieved in the reaction. In 1997, Leeper and Rawal introduced a bicyclic thiazolium-derived 
catalyst that provided an important basis for future catalyst design, despite no improvement in the 
enantioselectivity of the reaction over Sheehan’s original report.17 A major advance was later 
reported by Enders using a triazolium-derived scaffold, which provides the product with much 
improved enantioselectivity (75% ee).18 This was followed up by a bicyclic triazolium-derived 
catalyst that provided the benzoin product in high enantioselectivity for the first time (90% ee).19 
Currently, the most selective catalyst for the asymmetric benzoin reaction, reported Connon and 
Zietler delivers the product in 99% ee.20  
 
Figure 1.2.1 Catalyst development for the asymmetric benzoin reaction. 
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This reaction is not limited to homo-benzoin reactions and a variety of cross-benzoin 
reactions have also been reported. Cookson reported an intramolecular cross-benzoin reaction of 
tethered aliphatic aldehydes in 1976.21 Importantly, the substrates lacked chemoselectivity issues 
between the two aldehydes; when more than one benzoin products is possible, a statistical mixture 
of products is observed. In the intermolecular cross-benzoin reaction, the product distribution 
could be controlled by increasing the amount of one coupling partner (Scheme 1.2.1).22 
 
Scheme 1.2.1  
Several groups aimed to improve the chemoselectivity issues inherent in the cross reaction. 
Johnson reported the use of acyl-silanes as an acyl anion equivalent, which essentially removed 
the chemoselectivity issues observed by other groups.23 Gravel could increase the selectivity of 
the cross-benzoin reaction between aliphatic aldehyde donors and aryl aldehydes acceptors 
through catalyst design.24 He proposes the selectivity arises from steric interactions between the 
larger catalyst and the aromatic aldehyde disfavor formation of the Breslow intermediate with the 
aryl aldehyde. Therefore, using the bulkier NHC catalyst will encourage the formation of the 
aliphatic aldehyde-derived Breslow intermediate which then preferentially reacts with the aromatic 
aldehyde. Thus, the [4.3.0]-bicyclic triazolium 14 delivers the benzoin product 9 in a 40:1 ratio 
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over the other three possible products. In contrast, sterically smaller [3.3.0]-triazolium 13 favors 9 
in only a 1.4:1 ratio over the other three possible benzoin products. Efforts to render this reaction 
asymmetric were met with limited success, but the cross-benzoin product could be generated in 
63% yield and a promising 40% ee (Scheme 1.2.2).  
 
Scheme 1.2.2 
In addition to the reaction between two different aldehydes, the cross-benzoin reaction has 
also been employed to couple aldehydes with imines and ketones. Enders reported the coupling of 
aldehydes and trifluoromethyl ketones in good yields and modest enantioselectivity (up to 85% 
ee).25 Ketoesters have been shown to be competent acceptors in the cross-benzoin reaction between 
aryl and aliphatic aldehydes and ethyl pyruvate by Connon and Zeitler.26 Other ketoesters were 
also competent in the reaction, but branched aliphatic ketones were less reactive. This process was 
later rendered asymmetric by Gravel using triazolium 15 as the precatalyst giving the expected 





Imines were first reported in cross-benzoin reactions to give -amino ketones by Murry 
and Frantz.28 The enantioselective cross-benzoin reaction between aldehydes and imines was first 
reported by Miller who employed a peptide-derived thiazolium catalyst to impart selectivity.29 A 
triazolium-derived catalyst was reported by Rovis for the cross-aza-benzoin reaction between 
aldehydes and N-Boc imines that offers improved selectivity and a more general substrate scope 
than the peptide-catalyzed reaction.30 In this methodology, the NHC can add to the imine 
generating a stable NHC-imine adduct, which is highly reversible in the presence of a weak acid. 
This is generated in the reaction by deprotonation of the triazolium with CsOAc. Trifluoromethyl 
ketimines have also been demonstrated to be competent substrates in the cross-aza-benzoin 
reaction. High enantioselectivity could be achieved in the reaction when triazolium 16 is used as 
the pre-catalyst. This triazolium was also effective in coupling other imines bearing an electron 
withdrawing group including iminoesters and iminonitriles with high yields and enantioselectivity 
(Scheme 1.2.4).31 The benzoin reaction remains the most studied NHC-catalyzed process and the 
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advances in catalyst design for this reaction were crucial to the development of new carbene 




1.3 Asymmetric Intermolecular Stetter Reactions 
The Stetter reaction proceeds, similarly to the benzoin reaction, by initial generation of an 
acyl anion equivalent. The addition of this acyl anion to a carbon-heteroatom double bond in a 1,2 
fashion leads to the benzoin product. However, in the Stetter reaction, this intermediate adds 
conjugately to Michael acceptor to give γ-functionalized ketones. This reactivity was 
systematically investigated by Stetter during the 1970’s using cyanide or achiral thiazolium-
derived catalysts.12,32  
The intramolecular version of the reaction proved much more amenable toward the 
development of an asymmetric variant. This was first reported by Enders in 1996 using triazolium 
9 
 
precatalyst 17.33 The Rovis group published highly efficient catalyst scaffolds for this reaction in 
2002, providing the products in high yield and enantioselectivity (Scheme 1.3.1).34  
 
Scheme 1.3.1 
Since these initial reports, our group35 and others36 have reported a variety of catalysts for 
the efficient coupling of aldehydes to Michael acceptors. The scope of the reaction has also been 
expanded dramatically to include unsaturated amides, thioesters, ketones, esters, phosphonates and 
aldehydes. The mechanism of the intramolecular Stetter reaction was studied experimentally by 
Rovis.37 Through competition experiments, it was determined that the rate limiting step of the 
reaction is likely deprotonation to form the Breslow intermediate (Scheme 1.3.2). Interestingly, 
this is experimental evidence for previous computational investigations into the mechanism that 
found a high barrier for the symmetry forbidden 1,2-proton transfer (29.2 kcal/mol), which 
suggests the mechanism is proceeding in an alternate path. In a separate study, the proton transfer 
to generate the Breslow intermediate had a >43 kcal/mol barrier for the 1,2-proton shift, which 
could be reduced to 21 kcal/mol when an exogenous base (triethylamine) shuttles the proton.38 
Finally, Yates found that the mechanism for the Stetter reaction is different than the benzoin 
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reaction by following a two-step process for addition of the Breslow intermediate to the Michael 
acceptor, rather than a one step process as in the benzoin reaction.39 
 
Scheme 1.3.2 
Although the asymmetric intramolecular Stetter reaction has been demonstrated with many 
substrates, expanding the scope of the enantioselective intermolecular Stetter reaction has proven 
more difficult because the reaction often requires highly activated Michael acceptors to achieve 
good reactivity. First attempts at an enantioselective variant of this reaction were reported by 
Enders in 1990 coupling butenal with chalcone. The corresponding 1,4-diketone was generated in 
29% yield and 30% ee. The enantioselectivity could be slightly improved (39% ee) with a different 
thiazolium-derived catalyst, but reactivity drops off significantly (4% yield).40 The first major 
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advances toward developing an asymmetric intermolecular Stetter reaction were reported in 2008. 
Rovis reported the coupling of glyoxamides to alkylidene malonate acceptors with good yield and 
high enantioselectivity.41 The use of trisubstituted alkylidene ketoamides was later demonstrated 
to give the Stetter product with high levels of diastereocontrol.42 Concurrently, Enders published 
the coupling of aryl aldehydes to chalcones in good yield and modest enantioselectivity (Scheme 
1.3.3).43 Subsequently, acetaldehyde was demonstrated to be a competent coupling partner in the 
reaction, but with lower levels of enantioselectivity.44 
 
Scheme 1.3.3 
Following these seminal reports, the coupling of heteroaryl aldehydes to nitroalkenes was 
demonstrated.45 Fluorinated catalyst 19 was found to give the Stetter products in higher 
enantioselectivity compared to the non-fluorinated catalyst 18 demonstrating the impact of 
fluorination of the catalyst backbone on the efficiency of the catalyst (Scheme 1.3.4). This catalyst 
was further applied to the coupling of aryl aldehydes to unsaturated ketoesters.46 The improved 
selectivity with this catalyst was originally proposed to result from conformational changes in the 
catalyst that enhance the steric environment around the carbene center on the catalyst. A 
subsequent computational study found the selectivity could arise from attractive interactions on 
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the developing positive charge of the Breslow intermediate and the developing negative charge of 
the nitroalkene during the carbon-carbon bond forming step.47 
 
Scheme 1.3.4  
Triazolium 19 was later used to expand the scope of the Stetter reaction to include the 
coupling of α,β-unsaturated aldehydes with nitroalkenes.48 Interestingly, adding catechol to the 
reaction greatly increased the yield of the process, going from 5% yield after 8 hours to 80% yield 
after 2 hours. The addition of catechol to the intramolecular Stetter reaction was also tested and 
permitted catalyst loadings as low as 0.1 mol%. The increased activity from adding catechol to the 
reaction mixture was proposed to stem from catechol assisting the proton transfer of the tetrahedral 
intermediate to generate the Breslow intermediate (Scheme 1.3.5). This hypothesis is based on 
previous mechanistic studies on the intramolecular Stetter reaction which demonstrate that proton 
transfer to generate the Breslow intermediate is likely the rate limiting step of the intramolecular 
Stetter reaction.37 Kinetic isotope measurements with deutero-aldehyde and deutero-catechol 
support that catechol is assisting the proton transfer giving a kH/kD = 4.2. Alternatively, the 
increased reactivity could result from hydrogen bonding to the nitroalkene, activating it toward 
nucleophilic addition; however, Further control experiments with chiral diols and achiral NHC 
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catalysts give racemic Stetter product, suggesting the enhanced reactivity is not a result of 
activation of the Michael acceptor by hydrogen bonding. 
 
Scheme 1.3.5 
Aliphatic aldehydes could also be coupled to nitroalkenes. In this case, the trans-
fluorinated NHC 20 was more efficient than either 18 or 19 (Scheme 1.3.6). This was also studied 
computationally and it was again proposed that electrostatic interactions between the fluorine on 





Chi reported enal coupling partners with modified chalcones in good yield and 
enantioselectivity.49 While the scope of Michael acceptors in this reaction is generally limited to 
highly activated Michael acceptors, there have been reports using less activated substrates. The 
coupling of aryl aldehydes to acetamido-acrylates proceeds with good yield and 
enantioselectivity.50 This was later expanded to α-substituted acrylates lacking a second activating 
group.51 These reactions are limited to the use of α-substituted Michael acceptors. Importantly, the 
use of β-substituted enoates gives the product in diminished yield and enantioselectivity. When Z-
methyloct-2-enoate is used in the reaction, the Stetter product is afforded in 59% yield and 80% 
ee (Scheme 1.3.7). This is the only published example of an asymmetric Stetter reaction carried 
out on a β-substituted Michael acceptor lacking highly activating groups. 
 
Scheme 1.3.7 
1.4 Annulation Reaction Involving Extended Breslow Intermediates 
As mentioned above, α,β-unsaturated aldehydes can be used in umpolung acyl anion 
reactions, but because of the conjugated alkene, enals are also capable of substitution at the alpha 
or beta positions providing an alternate reactivity pathway that is not accessible with other 
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aldehydes (Scheme 1.4.1). Nucleophilic addition at the beta carbon of the extended Breslow 
intermediate 21 to an electrophile generates an enol azolium (22), which can also intercept 
electrophiles at the alpha position of the aldehyde. Protonation of the azolium enolate generates 
the electrophilic acyl azolium species 23, which can then be intercepted by a nucleophile to release 
the carbene catalyst and form the desired product. 
 
Scheme 1.4.1  
 Often this type of reactivity is carried out with a tethered nucleophile that can add to the 
acyl azolium generated to give cyclic products. A variety of annulation reactions are possible 
which can proceed by functionalization at the beta position through the homoenolate intermediate 
followed by cyclization onto either the enol azolium in a [4+2] fashion or at the acyl azolium to 
give [3+3] cycloaddition-type products. Cyclic products can also be accessed by initial beta 
protonation of the homoenolate intermediate to generate the enol azolium, which has been used to 
generate 5- and 6-membered rings. 
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 NHC-catalyzed homoenolate annulation reactions were first reported by Bode52 and 
Glorius53 in 2004 who demonstrated the synthesis of γ-lactones from enals and aryl aldehydes. 
This reactivity can also be exploited to synthesize γ-lactams, which was first reported by Bode in 
2005 using IMES as the NHC precursor (Scheme 1.4.2.).54 The proposed reaction is believed to 
proceed by initial formation of the Breslow intermediate 24, which then adds at the beta position 
to the aromatic aldehyde to give intermediate 25. This can then tautomerize to acyl azolium 26 
followed by intramolecular trapping of 26 by the tethered alkoxide to form the observed lactone 
product and regenerate the NHC catalyst.  
 
Scheme 1.4.2 
Since this initial report, several other studies have expanded the scope of the reaction 
demonstrating a variety of enals and aldehydes are tolerated as well as ketones55 and isatins.56 An 
enantioselective version of this reaction was reported by Scheidt, but was limited to 
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acylphosphonates as the carbonyl partner.57 Shortly after, the asymmetric homoenolate addition to 
cyclic ketimines was reported.58 Scheidt reported a synthesis of γ-lactams from N-acyl hydrazones 
and enals (Scheme 1.4.3).59 Interestingly, a Lewis acid co-catalyst was required to achieve high 
levels of reactivity and selectivity. It is proposed that the hydrazone is first activated by binding to 
the Lewis acid co-catalyst, followed by nucleophilic addition of the homoenolate equivalent. Rovis 
reported that a chiral NHC with catalytic amounts of a Brønsted acid enables the synthesis of γ-
lactams in good yield and enantioselectivity.60 A related annulation reaction was reported by 
Scheidt who found that aryl nitrones can undergo a beta functionalization followed by trapping 
with the tethered nitrone-oxygen.61 The [3+3] cycloadduct could then be opened with sodium 





1.5 Non-Ring Forming Reactions  
Although much less common, the umpolung beta functionalization of enals can also be 
employed where the acyl azolium is not intercepted by a tethered nucleophile. The first NHC-
catalyzed reactions involving beta functionalization of enals were reported by Scheidt62 and Bode63 
who developed an internal redox esterification process where the extended Breslow intermediate 
is first protonated at the beta position of the aldehyde to generate an azolium enolate (Scheme 
1.5.1). This can then undergo proton transfer to form an acyl azolium species, which is intercepted 
by an alcohol to give the saturated ester and regenerate the NHC catalyst. This mirrors reactivity 
reported forty years prior by Walia and Vishwakarma where cyanide was demonstrated to catalyze 





Nair reported a beta addition of enals to nitroalkenes generating functionalized δ-nitroesters, 
which is believed to proceed by generation of the homoenolate equivalent, followed by conjugate 
addition to the nitroalkene. Liu65 and Rovis66 later published enantioselective versions of this 
reaction. Interestingly, the method reported by Nair and the enantioselective variant reported by 
Liu favor formation of the anti-isomer, while the syn product was favored when catalyst 28 was 





The change in diastereoselectivity was proposed to result from an inversion in the Breslow 
intermediate geometry, which would allow for the reaction to occur on the same enantiotopic face 
of the enal, despite the pseudo-enantiomeric catalysts used in this methodology. It has also been 
proposed that Liu’s reaction proceeds via an open transition state (29) which leads to the formation 
of the anti-diastereomer. In Rovis’ case, the reaction is proposed to proceed through a closed 
transition state (30) which gives the syn product (Scheme 1.5.3). The mechanism and 
stereochemical outcome were later studied computationally and a transition state barrier of 15.3 
kcal/mol was calculated for the syn product.67 A possible reason for the high syn 
diastereoselectivity of the reaction results from lowering steric interaction on the enal and 
nitroalkene substituents in the C-C bond-forming step, as well as hydrogen bonding between the 
enol oxygen of the Breslow intermediate and the nitro group. Combined, these interactions lower 






Despite a resurgence of interest in NHCs as organocatalysts after the landmark papers of 
Bertrand1 and Arduengo2 that elucidated the structure of these stable carbenes, it was not until the 
2000’s that broad interest was generated. During this time, many new reactivity pathways were 
discovered and consequently, more efficient catalysts. Importantly, triazolium-derived NHCs were 
quickly identified as modular, easily modifiable catalysts that could impart high selectivity across 
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Aside from being a privileged structure in drug discovery, 1,4-dihydropyridines are also 
useful intermediates en route to other classes of important drug scaffolds. This important class of 
pharmaceuticals is used to treat an assortment of illnesses and have demonstrated antimicrobial, 
anticancer, antihypertensive, and anticonvulsant activity.1 In addition to the interest in these 
scaffolds as important drug molecules, dihydropyridines allow for easy synthetic entry into other 
substituted 6-membered heterocycles, such as pyridines and piperidines, and have the potential to 
streamline pharmaceutical syntheses.2 
Despite the importance of the 1,4-dihydropyridine scaffold, direct and mild methods for 
their synthesis remain scarce. Condensation reactions, as in the Hantzsch ester synthesis, have 
historically been used to generate 1,4-dihydropyridines.3 Asymmetric condensation reactions have 
also been reported.4 Another strategy for the synthesis of dihydropyridines is the nucleophilic 
dearomatization of activated pyridines.5 Many of the syntheses are racemic and often require 
strong nucleophiles (e.g. Grignards reagents) in stoichiometric amounts. To overcome this, chiral 
N-substituents on the pyridinium have been used to impart stereoselectivity for the 
diastereoselective synthesis of 2,3-dihydropyridines.6 This strategy can also be used to generate 
1,4-dihydropyridines when the pyridine has a chiral auxiliary at the 3-position.7 More recently, 
transition metal-catalyzed reactions have been applied to the asymmetric synthesis of 
dihydropyridines. Several nucleophiles have been coupled to pyridiniums including cyanide,8 
alkynal cuprates,9 dialkyl zincs,10 and aryl boronic acids.11 This strategy was also employed to 
cyclize tethered iridium-π-allyl species that were generated in situ from allyl carbonates.12 
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Although much less common, organocatalytic methods have also been developed. Anion-
binding catalysis has been demonstrated to be an effective enantioselective strategy for the 
nucleophilic dearomatization of N-Troc pyridiniums (Scheme 2.1.1).13 This method favored 
addition of silylenol ethers at the 2-position of the pyridinium, except in the cases where the 
pyridinium is substituted at the 3-position, in which case, addition at the 4-position is favored.  
High enantioselectivity could be achieved with certain substrates (up to 98% ee). However, 
enantioselectivity drops off dramatically when addition at the 4-position is observed (62-80% ee). 
This method could be extended to coupling indoles with pyridiniums, which gives the 1,4-
dihydropyridine with high regioselectivity (10:1 rr) and enantioselectivity.14 
 
Scheme 2.1.1 
More recently, enamine catalysis with chiral secondary amines was demonstrated as an 
efficient way to couple aldehydes at the alpha position to highly activated pyridiniums (Scheme 
2.1.2).15 Due to racemization, a one-pot procedure was developed where the product is 
immediately treated with Wittig salts to convert the product aldehyde to a γ-substituted enoates, 
before isolation. Following the two-step protocol, the dihydropyridine products were isolated in 
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good yields, with high levels of diastereo- and enantioselectivity (up to 19:1 and 99% ee) when 3-
nitropyridiniums are used as the substrate. However, 3-cyanopyridiniums generate the product 
with lower levels of diastereoselectivity (3:1 dr). 
 
Scheme 2.1.2 
2.2 Development of the Racemic Reaction 
We envisioned that the NHC-catalyzed homoenolate reactivity of enals could be utilized 
for the nucleophilic dearomatization of pyridinium ions to generate 1,4-dihydropoyridines 
stereoselectively. This method could potentially couple pyridiniums with enals to provide the 1,4-
dihydropyridine product directly from simple starting materials and provide a rare example of 
direct 1,4-dihydropyridine synthesis by catalytic nucleophilic dearomatization of pyridiniums. 
We began our studies of this reaction by first investigating the racemic reaction. Initially, 
the reaction was conducted with achiral trichloro-triazolium 31 using cinnamaldehyde as the enal 
to give the product in 30% yield and 1:1 dr (Scheme 2.2.1). When catalysts bearing more electron 
rich aryl rings were used, no desired reactivity was observed and the pyridinium decomposed under 
the reaction conditions. Interestingly, more catalysts bearing more electron-deficient aryl groupgs 
(e.g. pentafluorophenyl catalyst 32) delivers the product in much higher yields (79%). Despite the 
promising trends with reactivity when different achiral catalysts were tested, the 





 After screening several different catalysts in the reaction, we then tried different classes of 
aldehydes to investigate the influence of the aldehyde on the selectivity of the reaction (Scheme 
2.2.2). As shown above, cinnamaldehyde gives the expected product in high yield, but with no 
control of the diastereoselectivity. Ethyl butanoate and the conjugated 2,4-hexadienal also give the 
product with low levels of diastereocontrol. We also tried an aliphatic enal, Interestingly, the 
aliphatic aldehyde gives the product in 40% yield and 3:1 dr and was the only aldehyde class found 





2.3 Development of the Asymmetric Reaction 
After discovering the high reactivity of the achiral catalyst 19, combined with modest levels 
of diastereoselectivity with aliphatic enals in the reaction, we began investigating the asymmetric 
variant (Scheme 2.3.1). We first tested several different chiral catalysts in the reaction and found 
that high levels of enantioselectivity could be achieved, but the reaction required high catalyst 
loadings (20 mol%) and yields remained low (14-58%). 
 
Scheme 2.3.1 
After the initial catalyst screen, different conditions were investigated. However, when the 
reaction is run in solvents other than methanol there is a complete loss of the desired reactivity. 
We believed that the reason for the low reactivity in methanol could be a result of NHC addition 
to the pyridinium that leads to catalyst deactivation by oxidation of the NHC-pyridinium adduct. 
Thus, the three most selective catalysts were chosen and the reactions were conducted under an 
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inert atmosphere. Exclusion of oxygen from the reaction leads to a marked increase in the yields 
(as high as 87% yield) without affecting the selectivity. Encouraged by these results, the reaction 




Due to the lack of oxygen in these conditions, the NHC-pyridinium adduct is likely not 
being oxidized, but there could be an equilibrium that exists between the NHC-pyridinium adduct 
and the free carbene. We believed that while the unproductive addition of the NHC to the 
pyridinium was not leading to catalyst death when oxygen is removed from the reaction, it could 
possibly sequester the free carbene and arrest catalysis. Further studies were performed to test the 
validity of this hypothesis and are discussed in the mechanism and stereochemistry section of this 
chapter. To overcome the low yields when using 10 mol % catalyst loading, we then screened a 
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variety of additives in the reaction. Lewis acids added in 20 mol % were added to the reaction, but 
deliver none of the desired product, instead leading to oxidation of the enal to the enoate or no 
reaction (results not shown). Interestingly, addition of 20 mol % acetic acid to the reaction mixture 




2.4 Scope of the Reaction 
 A variety of N-substituents on the pyridinium were tolerated including alky groups. 4-
bromenzyl and 4-methoxybenzyl groups were also tolerated without affecting the selectivity or 
yield of the reaction. In general, variations on the N-alkyl substituent had little effect on the 
reactivity or selectivity, although the regioselectivity decreases somewhat as the N-group becomes 
smaller. However, carbamates on the nitrogen of the pyridinium led to a complete loss of reactivity. 
An electron withdrawing group at the 3-position of the pyridinium was required to achieve good 
reactivity with the cyano group providing the dihydropyridine with the highest enantioselectivity. 
Acetyl pyridinium 34 was tolerated, but the enantioselectivity was much lower. Interestingly, the 
diastereoselectivity and regioselectivity are slightly higher compared to the cyano group. Other 
electron-withdrawing groups, including the N-benzyl pyridiniums derived from methyl nicotinate, 
nicotinic acid and nicotinamide, were also tried in the reaction, but gave only trace amounts of 
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product. 2-methyl-5-cyano pyridinium was tolerated in the reaction, eliminating the 
regioselectivity issues (Scheme 2.4.1).  
 
Scheme 2.4.1 
 A wide variety of aliphatic and aryl enals were also tolerated in the reaction with varying 
levels of reactivity and selectivity. Straight-chain aliphatic enals proceed with the highest 
enantioselectivity. Branched aliphatic aldehydes participate in the reaction, but deliver the product 
in only marginal ee (c.f. products 45 & 46). Interestingly, the only exception to the depressed 
enantioselectivity with branched, aliphatic substrates was a cyclopropyl substituted enal that gives 
the corresponding dihydropyridine product 44 in comparable enantioselectivity to the straight 
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chain substrates. Cinnamaldehyde, as well as other conjugated enals, are competent coupling 
partners and proceed with good yield, but with much lower levels of selectivity (Scheme 2.4.2). 
 
Scheme 2.4.2 
 A variety of other pyridiniums and heterocycles were tested in the reaction, but did not 
give the desired product, instead giving the saturated ester byproduct or no reaction (Scheme 
2.4.3). The lack of reactivity observed when highly electron withdrawing groups are present (e.g. 
3-nitropyridinium) likely results from an irreversible addition of the NHC to the pyridinium 
causing catalyst deactivation. In the other cases, the pyridinium is not electrophilic enough to 
undergo addition with the Breslow intermediate, and the free carbene is still active. This allows 
for the formation of the saturated ester product by protonation of the Breslow intermediate at the 
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β-position of the enal, followed by tautomerization of the resulting enol azolium. This can then be 
intercepted by methanol to deliver the ester byproduct. 
 
Scheme 2.4.3 
2.5 Mechanism and Stereochemistry 
Based on recent reports of single-electron coupling pathways,16 we wondered whether this 
reaction could be proceeding via a one or two electron mechanism. Cyclic voltammetry was carried 
out to test this hypothesis. From these experiments, we determined that the pyridinium undergoes 
a quasi-reversible reduction at -0.77 V vs SCE. A related unsaturated aza-Breslow intermediate 49 
has been previously isolated and characterized (Scheme 2.5.1). This species was found to have a 
reduction potential of E= -0.49 V vs SCE in acetonitrile. This suggests that it is unlikely the 
pyridinium ion is incapable of oxidizing the Breslow intermediate in the reaction. Further evidence 
of this comes from recent reports of single electron oxidations of the extended Breslow 
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intermediate, followed by functionalization of the beta position. In these reactions, electron-
deficient nitroaryl compounds are believed to oxidize the Breslow intermediate to generate a 
radical cation, radical ion pair, which can recombine to give the observed beta hydroxylation 
products. The oxidants in these reactions have a reduction potential of E= -0.26 to -0.33 V vs SCE. 
Nitrobenzene has a reduction potential of E= -0.49 V vs SCE, which is right in line with the 
extended aza-Breslow intermediate, and delivers the product in trace amounts, suggesting that 
oxidants with a reduction potential below E= -0.49 will not be oxidizing enough to oxidize the 

















Because the reduction potential of the pyridinium is far outside the range of oxidants 
previously demonstrated to oxidize the Breslow intermediate, we believe the mechanism proceeds 
via a two-electron pathway as shown in scheme 2.5.2 where the extended Breslow intermediate is 




 During the optimization of the reaction, we found that the yield is drastically improved 
when oxygen is removed from the reaction. The absence of the saturated ester product, arising 
from trapping of the homoenolate equivalent with a proton, could suggest that the carbene adds 
reversibly to the pyridinium forming a 1,4-dihydropyridine which acts as a catalyst resting state. 
This adduct (50) could potentially be oxidized by oxygen leading to catalyst death and would 
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explain the low yields of the reaction when oxygen is present. This type of catalyst inhibition was 
previously noted by our group17 while investigating cross aza-benzoin reactions between 
aldehydes and imines. In these cases, it is believed that the carbene can reversibly add to the imine 
and if oxidized by oxygen in the air, lead to catalyst death. In the case of N-Boc imines, the addition 
of acetic acid was found to restore catalytic activity to the reaction. Further studies on these aza-
Breslow intermediates revealed that when treated with acid, they generate the free carbene and the 
corresponding imine.18 In this case, with pyridiniums, the carbene can add to the pyridinium 
generating either a 1,4 or 1,2-dihydropyridine which can also be thought of as an aza-Breslow 
intermediate or a vinylogous aza-Breslow intermediate in the case of 1,4-addition. To test this 
hypothesis, an equimolar amount of achiral catalyst was mixed with the pyridinium at rt and stirred 
for 2 hours. After this time, 1H NMR and mass spectrometry revealed the presence of the carbene-
pyridinium adduct in roughly 30% conversion by 1H NMR (Scheme 2.5.3). 
 
Scheme 2.5.3 
 Further evidence for the reversible addition of the NHC to the pyridinium was found when 
the reaction was conducted in MeOH-d1 with 20 mol % acetic acid-d1. After completion of the 
reaction, 1H NMR revealed 66% deuterium incorporation at the 2-position of the dihydropyridine 
product. Deuterium was also incorporated at the 2-position of the pyridinium (75% D 
incorporation) and at the 6-position (39% D incorporation). This result suggests that the NHC adds 
to the pyridinium to generate aza-Breslow intermediate 50, which can undergo protonation to give 
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the corresponding azolium. This can then be eliminated to regenerate the pyridinium and free 
carbene (Scheme 2.5.4). 
 
Scheme 2.5.4 
Finally, the absolute stereochemistry of the product was confirmed to be the R,S-
enantiomer  by  X-ray crystallography. From the crystal structure, it is apparent that the favored 
diastereomer is the R-S conformation. This stereochemical outcome matches a previous 
diastereoselective beta-functionalization reaction of enals to nitroalkenes that was carried out using 
the same catalyst (Scheme 2.5.5).19 The mechanism and stereochemical outcome of the nitroalkene 
coupling was studied computationally and a transition state barrier of 15.3 kcal/mol was calculated 
for the syn product.20 One possible reason for the high syn diastereoselectivity of the reaction 
results from lowering steric interaction on the enal and nitroalkene substituents in the C-C bond-
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forming step. Due to the similarity of these two reactions, these interactions could also be operative 
in the coupling of enals and pyridiniums. 
 
Scheme 2.5.5 
2.6 Product Derivatization 
 The products of these reactions could be further elaborated to other interesting motifs 
relevant to drug discovery. The N-allyl substituted 1,4-dihydropyridine product can be deprotected 
using palladium (0) and barbituric acid. The deprotected 1,4-dihydropyridine is rapidly oxidized 





Treatment of the 1,4-dihydropyridine with Pd(OH)2 reduces the more electron rich alkene 
selectively and avoids over-reduction to the piperidine. The piperidine could be accessed by 
reduction with triethylsilane and TFA in DCM. This gives the expected piperidine in 70% yield 
and proceeds without eroding the previously generated stereocenters. This could be deprotected 




 In conclusion, an NHC-catalyzed method of the nucleophilic dearomatization of N-alkyl 
pyridines was developed. This method enables the rapid synthesis of alkyl 1,4-dihydropyridines 
and the products could be further elaborated to other important scaffolds. The reaction proceeds 
with high enantioselectivity and favors formation of the 1,4-dihydropyridine over the 1,2-
dihydropyridine. The reaction tolerates a range of enals in the reaction; however, selectivity is 
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lower when conjugated or branched aliphatic enals are used. The pyridinium scope is broad and 
tolerates many different N-substituents along with different electron withdrawing groups at the 3-
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3.1 Asymmetric Intermolecular Stetter Reactions with α,β-unsaturated Ketones 
Although there has been a significant amount of work on the asymmetric intermolecular 
coupling of aldehydes to Michael acceptors, these are generally limited to very activated 
substrates. The first advances in the asymmetric intermolecular Stetter reaction came in 2007. 
Enders1 coupled aryl aldehydes with chalcones and Rovis demonstrated a highly enantioselective 
coupling of glyoxamides to alkylidene malonates.2 Since these initial reports, the scope of Michael 
acceptors in the reaction has been expanded to include nitroalkenes,3 chalcone derivatives,4 
ketoesters,5 and enoates (Figure 3.1).6 The scope of aldehyde coupling partners in the reaction is 
much more broad and a variety of aryl, heteroaryl, α,β-unsaturated, and aliphatic aldehydes have 
been successfully employed in the reaction.6a 
 
Figure 3.1 Scope of Michael acceptors in the asymmetric Stetter reaction. 
Despite the progress expanding the scope of the asymmetric intermolecular Stetter 
reaction, the use of Michael acceptors lacking aromatic substitution or a second electron-
withdrawing group remains an enormous challenge of this methodology, limiting its broad 
application in synthesis. The use of 1,1-disubstituted enoates has been demonstrated in the reaction 
and the success of this methodology relies on the use of carbene catalysts with highly donating N-
aryl substituents to increase the reactivity of the catalyst. Additionally, the reactivity and selectivity 
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of the reaction depends on the absence of beta substituents on the Michael acceptor. This class of 
substrates (lacking beta substituents) have been previously demonstrated to be much more reactive 
in the cyanide and thiazolium-catalyzed reactions.7 Thus, while these substrates greatly expanded 
the scope of Michael acceptors, there is still a need for catalysts that can reliably couple aldehydes 
to less activated Michael acceptors bearing a beta substituent. To date, there has been only one 
reported example of a simple beta substituted Michael acceptor delivering the Stetter product with 
appreciable levels of enantioselectivity (Scheme 3.1.1).  
 
Scheme 3.1.1 
Due to the lack of methods for the asymmetric intermolecular Stetter reaction with simple 
Michael acceptors, we became interested in using beta substituted Michael acceptors with simple 
enones or equivalents that lack secondary activating groups. The realization of this strategy would 
significantly expand the scope of this methodology and contribute to its utility in synthesis. 
We began our investigation by screening a variety of achiral catalysts in the reaction with 
furfural and 4-phenylbutenone. (Scheme 3.1.2) Under these initial conditions, the reactivity of 
these catalysts was highly variable with the tri-halogenated aryl groups as the N-substituent 
providing (51 and 52) the product in the highest yield (58% and 73% yield, respectively). 
Interestingly, the mesityl-substituted catalyst gives the product in 20% yield, much higher than the 
other carbenes bearing electron-donating groups, and roughly equivalent to the tribromo-difluoro 
catalyst tested. These results suggest that the steric environment imparted by substituents ortho to 
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the triazolium impact the reactivity of the carbene. However, the electronics also impact reactivity 
comparing 51 and 52 which give the product in 58% and 21% yield, respectively, implying that 
very electron-withdrawing aryl groups on the catalyst inhibit reactivity. 
 
Scheme 3.1.2 
Using catalyst 52, we then screened a variety of aldehydes and enones in the reaction to 
probe the reactivity. Disappointingly, replacement of the beta phenyl substituent with an aliphatic 
group completely inhibits reactivity. The only reactivity that was observed in these reactions was 
with furfural, which selectively forms the benzoin product, but does not add to the Michael 
acceptor. No reactivity was observed with either enals or aliphatic aldehyde. A variety of bases 
and solvents were then screened with aliphatic aldehydes coupling to 4-phenylbutenone; however, 







 With the trends of the racemic reaction in mind, we then turned our attention toward the 
asymmetric reaction. Due to the much higher reactivity of the trichlorophenyl catalyst in the 
racemic reaction, we chose to initially screen chiral catalysts bearing the same N-substituent. We 
first attempted the reaction using chiral catalyst 53. Using this catalyst, the selectivity was 




 Switching to a weaker base in the reaction proved deleterious to reactivity and selectivity. 
Sodium acetate gives the product in trace amounts, while Cs2CO3 gives 22% yield and 15% ee. 
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Fluorinated catalyst 19 delivers the product with much higher enantioselectivity (80% ee vs 46% 
ee) than the catalyst lacking a fluorine in the backbone an energy difference of ~0.8 kcal/mol at 
room temperature. A similar effect was noted in the asymmetric intermolecular Stetter reaction 
between aryl aldehydes and nitroalkenes where the highest selectivity was achieved using catalyst 
19, which gives the Stetter adduct in 80% ee and 15% yield (Scheme 3.1.5).3c 
 
Scheme 3.1.5 
In addition to the optimization of the beta aryl enone, we also investigated enones with 
aliphatic substituents. This substrate class participates in the reaction, but is much less reactive and 
enantioselectivity is reduced. Switching the solvent from methanol to DMSO increased the yield 
and selectivity (21%, <5% ee in methanol compared to 40%, 28% ee in DMSO) when aliphatic 
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enones are used (Scheme 3.1.6). Interestingly, increasing the steric bulk of the substituent alpha to 
the ketone slightly increases the enantioselectivity of the process, despite being four carbons away 
from the reactive center. 
 
Scheme 3.1.6 
Due to the consistently low enantioselectivity of the reaction, we wondered whether the 
product could be epimerizing under the reaction conditions. To probe this, we ran the reaction in 
methanol-d4 and found that there is no deuterium incorporation at the newly generated stereocenter. 
Another experiment to probe possible epimerization is to add some of the diketone product to the 
reaction. Diketone 54 was added to the reaction mixture and no erosion of the ee was detected 
(Scheme 3.1.7). The lack of deuterium incorporation at the methine and complete deuteration at 
the methyl ketone suggests that deprotonation at this position is heavily favored over the methine 
stereocenter. Taken together, these experiments demonstrate that the low enantioselectivity of the 
reaction is not likely a result of epimerization of the methine stereocenter. Rather, we conclude 
that the stereocenter is controlled by the orientation of the addition of the Breslow intermediate to 





 In conclusion, the Stetter reactions with simple enones was investigated, and a variety of 
factors were found to influence the selectivity and reactivity of these substrates. The N-substituent 
appears to have a profound effect on the reactivity of the process with 2,4,6-trichlorophenyl 
substituted catalysts delivering product in higher yields. Epimerization studies demonstrated that 
the products are not racemizing under the reaction conditions despite the low enantioselectivity of 
the process across a range of catalysts and substrates. As noted in the case of nitroalkenes, 
backbone fluorination of the catalyst drastically boosts selectivity, but in the case of enones did 
not increase the yield. Despite the challenges associated with the reaction, we isolated the product 





3.2 Investigation of Electronic Effects of Triazolylidene Boryl Radicals 
 Boranes bearing an NHC ligand have become important reagents for organic chemistry as 
replacements for tin hydrides in free radical reactions.8 Applying this strategy, NHC-boranes have 
been used to effect a variety of transformations including hydroxymethylation with carbon 
monoxide,9 xanthate reduction,10 and reductive cyclizations.11 Additionally, they have been shown 
to be efficient co-initiators in the radical photopolymerization of acrylates.12  
Previous studies have investigated the relationship between the sterics of the NHC-borane 
and their reactivity.13 These studies clearly demonstrate that the reactivity of the NHC-borane can 
be attenuated by increasing the steric bulk of the NHC on the NHC-borane radical complex in H-
atom and halogen extraction reactions. Our group developed a modular synthesis of triazolium 
pre-catalysts for NHC catalysis that allows for the rapid synthesis of a variety of catalysts ranging 
from strongly electron-donating to heavily electron-withdrawing.14 Thus, these NHCs could be 
complexed to boranes to generate a library of NHC-boranes to probe the electronic effects on 
reactivity. In terms of organocatalysis, the N-aryl substituent has a recognized impact on reactivity 
due to a variety of steric or electronic factors.15 
 In collaboration with the Emmanuel Lacôte research group, a small library of NHC-boranes 
was prepared with varying electronics of the N-aryl substituent (Scheme 3.2.1). As my 
contribution, I synthesized trimethoxyphenyl triazolium that was converted to the NHC-Borane 
for use in this study. The rate constant of hydrogen abstraction with oxygen radicals using di-tert-
butyl peroxide or benzophenone as the radical source were then measured, along with the B-H 
bond-dissociation energies, and the rate of addition of the NHC-borane radical. These three 
parameters showed no correlation between the electronics of the N-aryl substituent and reactivity. 
In contrast, the addition of the NHC-boryl radical to acrylates was found to have a linear 
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correlation to the calculated electronegativity of the NHC-boryl radicals. As the electronegativity 
of the boryl radical decreases, the faster the addition to methyl acrylate. 
 
Scheme 3.2.1 
 While the rate of addition of NHC-boryl radicals to methyl methacrylate showed a strong 
linear correlation, this did not translate to the efficiency of the boryl radical as a co-initiator in the 
radical photopolymerization of trimethylolpropane triacylate. N-Pentafluorophenyl triazolium 
outperformed the other co-initiators, except for the dimethyl triazolium, despite having the slowest 
rate of addition to methyl methacrylate. This suggests that the rate-limiting step of the reaction is 
not the addition of the NHC-boryl radical to the acrylate. 
3.3 Synthesis of (–)-Paroxetine and (–)-Femoxitine 
 The rapid and stereodefined synthesis of piperidines is a topic that has had much attention 
from the synthetic community.16 Our group previously reported the highly enantio- and 
diastereoselective coupling of enals with nitroalkenes to give δ-nitroesters with high enantio- and 
diastereoselectivity.17 Using this methodology, a one-pot procedure was also developed for the in-
situ conversion of these δ-nitroesters into the corresponding δ-lactam, which proceeded without 
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eroding the newly defined stereocenters. The rapid access to trans 3,4-disubstituted piperidones 
enabled by this process inspired us to the synthesize the common selective serotonin reuptake 
inhibitors (SSRIs) Paroxetine and Femoxetine (Figure 3.3.1). Paroxetine (Paxil) and Femoxetine 
were discovered in 1970 as a treatment for depression, anxiety, and panic disorder. While 
Femoxetine was not pursued, Paroxetine was introduced to the market in 1992.18 
 
Figure 3.3.1 Structures of Paroxetine and Femoxitine. 
 The synthesis of Paroxetine began by generating nitroalkene 56 from commercially 
available aldehyde 55 using a Henry reaction with nitromethane, followed by elimination with 
trifluoroacetic acid to give 56 in 68% yield over two steps. My contribution to the synthesis of 
Paroxetine was the synthesis of aldehyde 55, which is commercially available from Aurora 
Building Blocks, but we chose to make it via a two-step process starting from sesamol. To 
synthesize 55, sesamol was first treated with 3-chloro-1,2-propane diol in the presence of sodium 
hydroxide to give the corresponding diol. This diol was then treated with sodium periodate (1.3 
equiv) to cleave the diol and generate 55 in 82% yield.Aldehyde 55 was then converted to the 
corresponding nitroalkene (56) in a two-step sequence to setup the NHC-catalyzed δ-lactam 
synthesis to complete the core of Paroxetine. Using triazolium 19, the one pot procedure for the 
synthesis of the 3,4-disubstituted piperidone was carried out, delivering 1.8 g of the product in 
58% yield, 10:1 dr, and 82% ee. Reduction of the δ-lactam to the corresponding piperidine 
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completes the synthesis, giving Paroxetine in 88% yield (35% over four steps), 10:1 dr, and 82% 
ee (Scheme 3.3.2).  
Scheme 3.3.2 
 
 This synthetic sequence could also be applied to the synthesis of Femoxetine, which was 
completed in 5% yield over 5 steps, 7:1 dr, and 82% ee (Scheme 3.3.3).19 The starting aldehyde 
was generated similarly by treatment of mequinol with 3-chloro-1,2-propane and sodium 
hydroxide, followed by sodium periodate to generate the corresponding aldehyde. This was then 
converted to the nitroalkene following two-step Henry reaction and elimination sequence to set up 
the NHC-catalyzed lactam synthesis. The lactam was then reduced to the piperidine with lithium 
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aluminum hydride. Finally, the N-methyl piperidine was generated using methyl iodide to complet 
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Materials and Methods 
 
All reactions were carried out with magnetic stirring under an atmosphere of argon in oven-dried 
glassware. Methanol was purchased from Sigma-Aldrich and stored in an anhydrous atmosphere. 
Sodium acetate was purchased from Aldrich and stored under anhydrous atmosphere.  
1H NMR spectra were recorded on Varian 400 MHz spectrometer at ambient temperature or a 
Bruker Avance III 500 (500  MHz). Data is reported as follows: chemical shift in parts per 
million (δ, ppm) from CDCl3 (7.26 ppm) or acetone-D6 (2.03 ppm), multiplicity (s = singlet, bs 
= broad singlet, d = doublet, t = triplet, q = quartet, and m = multiplet), coupling constants (Hz). 
13CNMR were recorded on Varian 400 MHz (at 100 MHz) spectrometer or a Bruker Avance III 
500 (125  MHz) at ambient temperature. Chemical shifts are reported in ppm from CDCl3 (77.36 
ppm) or acetoneD-6 (205.87, 30.6 ppm). Mass spectra were recorded on an Agilent 6130 
Quadrupole LC/MS. HPLC spectra were obtained on an Agilent 1100 series system. Optical 
rotations were obtained on an Autopol - III automatic polarimeter or a Jasco DIP - 1000 digital 
polarimeter. Infrared spectra were recorded on a Perkin - Elmer Spectrum Two (Diamond  ATR) 
IR  or a Nicolet iS-50 FT-IR spectrometer. Thin layer chromatography was performed on 
SiliCycle® 250μm 60A plates. Visualization was accomplished with UV light or KMnO4 stain 
followed by heating. 
 
General Procedure for the synthesis of dihydropyridine derivatives 
The 1,4-dihydropyridines were synthesized by combining 0.2 mmol of enal, 0.30 mmol 
pyridinium salt, 0.02 mmol NHC (10 mol%) and 0.2 mmol NaOAc in a vial equipped with a stir 
bar and Teflon cap. This mixture was then placed in an inert atmosphere (glove box) and diluted 
with 2 mL of methanol (0.1 M) along with 0.02 mmol acetic acid (20 mol%). The vial was then 
sealed and stirred at room temperature for 24 h. After this time, the solvent was evaporated and 
the crude reaction mixture was purified by silica chromatography (dry loading on celite) to 
afford the title compounds. 
 
methyl 3-(1-benzyl-3-cyano-1,4-dihydropyridin-4-yl)-5-
phenylpentanoate (33): Pale yellow oil. 61% yield, 5:1 rr, 3:1 dr, 88% ee. Rf = 0.3 (4:1 
Hexanes:EtOAc); [α]D
21 = -32.8 (c = 0.136 g/mL); HPLC analysis: Chiralpak IA column, 80:20 
hexanes/iso-propanol, 0.5 mL/min. Major: 18.1 min, minor: 16.8. 1HNMR: (500 MHz, 
Chloroform-d) δ 7.31 (dd, J = 4.7, 2.5 Hz, 5H), 7.23 (d, J = 6.0 Hz, 3H), 7.17 – 7.14 (m, 2H), 
6.74 (d, J = 1.5 Hz, 1H), 5.89 (d, J = 8.1 Hz, 1H), 4.63 (ddd, J = 7.2, 4.4, 2.7 Hz, 1H), 4.29 (s, 
2H), 3.69 (s, 3H), 3.48 (t, J = 3.7 Hz, 1H), 2.69 – 2.65 (m, 2H), 2.41 (dd, J = 7.1, 4.1 Hz, 2H), 
2.13 – 1.98 (m, 2H), 1.62 (qd, J = 5.5, 2.8 Hz, 2H). 13CNMR: (101 MHz, Chloroform-d) δ 
173.51, 144.24, 142.21, 136.07, 129.55, 129.02, 128.41, 127.12, 121.23, 103.51, 57.55, 51.68, 
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51.62, 41.73, 36.37, 35.66, 33.87, 33.04. IR (ATR, neat) 3026, 2923, 2856, 2191, 1730, 1672, 
1590, 1412, 1181, 735, 701 cm-1 LRMS (ESI + APCI) m/z [M+H] calcd 387.2, found 387.2 
methyl 3-(1-benzyl-3-cyano-1,4-dihydropyridin-4-yl)-5-
methylhexanoate (34): Pale yellow oil. 71% yield, 3:1 rr, 2:1 dr, 87% ee. Rf = 0.35 (4:1 
Hexanes:EtOAc); [α]D
21 = -12.2 (c = 0.01 g/mL); HPLC analysis: Chiralpak IA column, 90:10 
hexanes/iso-propanol, 1.0 mL/min. Major: 11.2 min, minor: 10.8 min. 1HNMR: (400 MHz, 
Chloroform-d) δ 7.33 (dd, J = 25.5, 7.9 Hz, 3H), 7.25 – 7.04 (m, 3H), 6.99 (d, J = 8.4 Hz, 2H), 
6.69 (d, J = 1.6 Hz, 1H), 5.91 – 5.76 (m, 1H), 4.61 (dd, J = 8.1, 4.4 Hz, 1H), 4.21 (s, 2H), 3.67 (s, 
3H), 3.52 – 3.40 (m, 1H), 2.80 – 2.56 (m, 2H), 2.42 – 2.27 (m, 2H), 2.21 – 1.92 (m, 2H), 1.76 – 
1.47 (m, 2H). 13CNMR: (101 MHz, Chloroform-d) δ 173.33, 143.92, 142.15, 129.30, 128.36, 
125.91, 122.19, 120.89, 103.67, 103.01, 81.70, 81.22, 56.91, 51.67, 41.57, 41.21, 36.40, 35.57, 
33.86, 33.16. IR (ATR, neat) 3060, 3025, 2923, 2857, 2191, 1729, 1672, 1591, 1435, 1404, 
1178, 1010 cm-1 LRMS (ESI + APCI) m/z [M+H] calcd 465.1, found 465.1 
 
methyl 3-(3-cyano-1-(4-methoxybenzyl)-1,4-dihydropyridin-4-yl)-
5-phenylpentanoate (35): Pale yellow oil. 50% yield, 6:1 rr, 3:1 dr, 85% ee. Rf = 0.3 (4:1 
Hexanes:EtOAc); [α]D
21 = -22.2 (c = 0.01 g/mL); HPLC analysis: Chiralpak IA column, 90:10 
hexanes/iso-propanol, 1.0 mL/min. Major: 12.0 min, minor: 10.8 min. 1HNMR: 1H NMR (400 
MHz, Chloroform-d) δ 7.33 – 7.27 (m, 3H), 7.23 – 7.15 (m, 5H), 7.09 (d, J = 8.8 Hz, 2H), 7.05 
(d, J = 8.8 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 6.79 (d, J = 8.7 Hz, 2H), 6.70 (d, J = 1.6 Hz, 1H), 
5.86 (ddd, J = 8.2, 1.7, 0.9 Hz, 1H), 4.59 (dd, J = 8.1, 4.4 Hz, 1H), 4.19 (s, 2H), 3.79 (s, 3H), 
3.66 (s, 3H), 3.46 – 3.41 (m, 1H), 2.80 – 2.59 (m, 4H), 2.34 – 2.22 (m, 1H), 2.15 – 1.94 (m, 3H), 
1.74 – 1.50 (m, 3H). 13CNMR: (101 MHz; CDCl3): δ 173.5, 159.5, 144.1, 142.2, 129.4, 128.5, 
128.4, 128.4, 127.9, 121.3, 114.4, 103.4, 80.4, 57.1, 55.3, 51.6, 41.8, 41.3, 36.4, 35.6, 33.9, 33.0 
IR (ATR, neat) 3061, 3026, 2925, 2856, 2191, 1731, 1672, 1588, 1513, 1412, 1248, 1175 cm-1 





phenylpentanoate (36): Pale yellow oil. 45% yield, 3:1 rr, 3:1 dr, 86% ee. Rf = 0.2 (4:1 
Hexanes:EtOAc); [α]D
21 = -19.3 (c = 0.01 g/mL); HPLC analysis: Chiralpak IA column, 90:10 
hexanes/iso-propanol, 1.0 mL/min. Major: 16.0 min, minor: 14.5. 1HNMR: 1H NMR (400 MHz, 
Chloroform-d) δ 7.30 – 7.28 (m, 3H), 7.21 – 7.16 (m, 2H), 6.64 (d, J = 4 Hz, 1H), 5.71 – 5.68 
(m, 1H), 5.84 – 5.82 (m, 1H), 5.25 – 5.17 (m, 2H), 4.58 (dd, J = 4, 8 Hz, 1H), 3.66 (s, 3H), 3.47 
– 3.43 (m, 1H), 2.75 – 2.62 (m, 3H), 2.45 – 2.25 (m, 2H), 2.05 – 1.96 (m, 2H), 1.68 – 1.56 (m, 
2H); 13CNMR: (101 MHz; CDCl3): δ 171 IR (ATR, neat) 3061, 3025, 2925, 2860, 2192, 1673, 
1591, 1412, 1218, 1189 cm-1 LRMS (ESI + APCI) m/z [M+H] calcd 337.2, found 337.2 
 
methyl 3-(3-cyano-1-(3-methylbut-3-en-1-yl)-1,4-dihydropyridin-4-
yl)-5-phenylpentanoate (37): Pale yellow oil. 38% yield, 4:1 rr, 2:1 dr, 89% ee. Rf = 0.3 (4:1 
Hexanes:EtOAc); [α]D
21 = 23.1 (c = 0.009 g/mL); HPLC analysis: Chiralpak OC column, 90:10 
hexanes/iso-propanol, 1.0 mL/min. Major: 40.0 min, minor: 37.8 min. 1HNMR: (400 MHz, 
Chloroform-d) δ 7.25 (d, J = 3.1 Hz, 1H), 7.23 – 7.12 (m, 4H), 6.59 (dd, J = 10.7, 1.6 Hz, 1H), 
5.90 – 5.80 (m, 1H), 4.86 – 4.63 (m, 3H), 4.57 (dd, J = 8.1, 4.4 Hz, 1H), 3.66 (s, 3H), 3.48 – 3.40 
(m, 1H), 3.20 (td, J = 7.1, 4.4 Hz, 2H), 2.66 – 2.57 (m, 2H), 2.37 (dd, J = 17.3, 7.0 Hz, 1H), 2.23 
– 2.15 (m, 3H), 2.06 – 1.94 (m, 2H), 1.70 (d, J = 12.7 Hz, 4H); 13CNMR: (101 MHz, 
Chloroform-d) δ 173.55, 144.01, 142.19, 140.81, 129.14, 128.37, 125.77, 123.61, 121.49, 
113.57, 109.19, 103.32, 79.47, 52.42, 51.60, 42.01, 41.30, 37.92, 36.15, 35.65, 33.82, 33.62, 
32.97, 32.46, 22.18. IR (ATR, neat) 3061, 3026, 2925, 2857, 1731, 1672, 1625, 1588, 1414, 
1170 cm-1; LRMS (ESI + APCI) m/z [M+H] calcd 365.2, found 365.2 
 
methyl 3-(3-cyano-1-propyl-1,4-dihydropyridin-4-yl)-5-
phenylpentanoate (38): Pale yellow oil. 46% yield, 3:1 rr, 3:1 dr, 88% ee. Rf = 0.3 (4:1 
Hexanes:EtOAc); [α]D
21 = -34.0 (c = 0.01 g/mL); HPLC analysis: Chiralpak IA column, 90:10 
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hexanes/iso-propanol, 1.0 mL/min. Major: 13.0 min, minor: 11.7 min. 1HNMR: (400 MHz, 
Chloroform-d) δ 7.33 – 7.27 (m, 1H), 7.23 – 7.11 (m, 3H), 6.63 (d, J = 1.6 Hz, 1H), 5.90 – 5.80 
(m, 1H), 4.60 – 4.53 (m, 1H), 3.66 (s, 3H), 3.48 – 3.40 (m, 1H), 3.08 – 2.98 (m, 2H), 2.67 – 2.56 
(m, 2H), 2.48 – 2.30 (m, 2H), 2.08 – 1.92 (m, 2H), 1.57 – 1.49 (m, 2H), 0.86 (t, J = 7.4 Hz, 
3H).13CNMR: (101 MHz; CDCl3): δ 173.56, 144.17, 142.17, 129.31, 128.34, 123.61, 121.59, 
101.85, 79.13, 55.86, 51.60, 42.02, 41.29, 36.19, 35.65, 33.78, 32.89, 23.14, 10.79 IR (ATR, 
neat) 3061, 3026, 2930, 2876, 2190, 1731, 1671, 1587, 1414, 1133 cm-1 LRMS (ESI + APCI) 




methylhexanoate (39): Pale yellow oil. 46% yield, >20:1 rr, 4:1 dr, 91% ee. Rf = 0.3 (4:1 
Hexanes:EtOAc); [α]D
21 = -11.6 (c = 0.01 g/mL); HPLC analysis: Chiralpak IA column, 90:10 
hexanes/iso-propanol, 1.0 mL/min. Major: 15.0 min, minor: 13.6 min. 1HNMR: (400 MHz, 
Chloroform-d) δ 7.36 – 7.27 (m, 3H), 7.26 – 7.14 (m, 6H), 7.11 (dd, J = 6.5, 3.1 Hz, 1H), 6.73 (s, 
1H), 4.53 – 4.32 (m, 3H), 3.67 (s, 3H), 3.51 – 3.42 (m, 1H), 2.78 – 2.58 (m, 3H), 2.40 (dd, J = 
7.0, 2.5 Hz, 1H), 2.16 – 1.95 (m, 2H), 1.75 (s, 3H), 1.65 – 1.51 (m, 1H). 13CNMR: (101 MHz, 
Chloroform-d) δ 173.57, 145.89, 142.27, 137.40, 135.40, 128.42, 128.38, 127.76, 125.99, 
121.20, 101.60, 81.05, 53.98, 51.61, 41.81, 37.40, 35.81, 33.94, 33.20, 18.72. IR (ATR, neat) 
3061, 3027, 2922, 2853, 2191, 1731, 1679, 1603, 1435, 1407, 1179, 1155 cm-1; LRMS (ESI + 
APCI) m/z [M+H] calcd 401.2, found 401.2 
 
 methyl 3-(3-acetyl-1-benzyl-1,4-dihydropyridin-4-yl)-5-
phenylpentanoate (40): Pale yellow oil. 46% yield, 4:1 rr, 5:1 dr, 50% ee. Rf = 0.2 (4:1 
Hexanes:EtOAc); [α]D
21 = -52.7 (c = 0.008 g/mL); HPLC analysis: Chiralpak IA column, 93:7 
hexanes/iso-propanol, 1.0 mL/min. Major: 71.8 min, minor: 78.2. 1HNMR: (500 MHz, 
Chloroform-d) δ 7.3a2 – 7.27 (m, 4H), 7.24 – 7.21 (m, 3H), 7.16 (d, J = 6.7 Hz, 4H), 5.98 (d, J = 
7.8 Hz, 1H), 4.96 – 4.87 (m, 1H), 4.41 (s, 2H), 3.71 (s, 3H), 2.70 – 2.54 (m, 2H), 2.34 (d, J = 7.3 
Hz, 2H), 2.19 (s, 4H), 2.10 (dd, J = 10.2, 6.0 Hz, 1H), 1.80 – 1.63 (m, 3H), 1.52 – 1.39 (m, 1H). 
13CNMR: (126 MHz; CDCl3): δ 195.27, 173.97, 143.48, 142.86, 136.52, 129.20, 128.94, 
128.39, 128.30, 128.00, 127.02, 125.61, 111.66, 106.15, 58.01, 51.55, 40.87, 36.00, 33.92, 32.64, 
24.65. IR (ATR, neat) 3026, 2923, 2856, 1730, 1667, 1574, 1454, 1434, 1387, 1177 cm-1. 





(benzyloxy)butanoate (41): Pale yellow oil. 63% yield, 3:1 rr, 4:1 dr, 81% ee. Rf = 0.3 (4:1 
Hexanes:EtOAc); [α]D
21 = -8.0 (c = 0.005 g/mL); HPLC analysis: Chiralpak IA column, 95:5 
hexanes/iso-propanol, 1.0 mL/min. Major: 35.6 min, minor: 44.2 min. 1HNMR: (400 MHz, 
Chloroform-d) δ 7.33 (q, J = 4.1, 3.5 Hz, 9H), 7.24 – 7.21 (m, 2H), 7.18 – 7.15 (m, 2H), 6.71 (d, 
J = 1.6 Hz, 1H), 6.05 – 5.97 (m, 1H), 5.87 (d, J = 8.9 Hz, 1H), 4.62 (dd, J = 8.0, 4.6 Hz, 1H), 
4.28 (s, 2H), 3.67 (s, 3H), 3.60 (s, 3H), 3.55 – 3.51 (m, 2H), 3.51 – 3.46 (m, 1H), 2.69 – 2.62 (m, 
1H), 2.45 – 2.39 (m, 2H), 2.38 – 2.33 (m, 1H). 13CNMR: (101 MHz; CDCl3): 13C NMR (101 
MHz, Chloroform-d) δ 173.31, 148.32, 144.17, 138.34, 135.97, 129.05, 128.26, 127.70, 127.22, 
123.34, 121.40, 110.04, 104.09, 73.10, 70.42, 68.08, 57.89, 57.57, 56.76, 51.55, 42.64, 39.52, 
34.24, 33.23, 31.23, 29.68. IR (ATR, neat) 3062, 3030, 2950, 2855, 2193, 1732, 1625, 1453, 
1246, 1103 cm-1; LRMS (ESI + APCI) m/z [M+H] calcd 403.2, found 403.2 
 
methyl 3-(1-benzyl-3-cyano-1,4-dihydropyridin-4-yl)-4-
methoxybutanoate (42): Pale yellow oil. 63% yield, 5:1 rr, 2:1 dr, 84% ee. Rf = 0.2 (4:1 
Hexanes:EtOAc); [α]D
21 = -33.6 (c = 0.005 g/mL); HPLC analysis: Chiralpak IA column, 80:20 
hexanes/iso-propanol, 1.0 mL/min. Major: 8.1 min, minor: 9.8 min. 1H NMR: (400 MHz, 
Chloroform-d) δ 7.36 (dt, J = 13.0, 6.8 Hz, 5H), 7.18 (d, J = 6.6 Hz, 2H), 6.72 (d, J = 1.6 Hz, 
1H), 5.89 (d, J = 8.0 Hz, 1H), 4.63 (dd, J = 8.1, 4.5 Hz, 1H), 4.30 (s, 2H), 3.69 (t, J = 4.2 Hz, 
2H), 3.65 (s, 2H), 3.55 (dd, J = 9.6, 6.6 Hz, 1H), 3.52 – 3.48 (m, 1H), 3.37 (dd, J = 9.6, 7.4 Hz, 
1H), 3.31 (s, 2H), 2.43 – 2.35 (m, 1H), 2.25 (dd, J = 6.9, 3.2 Hz, 1H); 13C NMR: (101 MHz, 
Chloroform-d) δ 173.35, 148.35, 144.19, 135.98, 129.29, 129.05, 128.29, 127.23, 123.36, 
121.37, 104.12, 79.78, 72.63, 58.77, 58.35, 57.60, 51.58, 42.59, 41.01, 39.46, 34.15, 33.03, 
31.45, 31.14. IR (ATR, neat) 2950, 2925, 2192, 1730, 1672, 1589, 1413, 1179, 1118 cm-1 




(43): Pale yellow oil. 63% yield, 4:1 rr, 3:1 dr, 84% ee. Rf = 0.2 (4:1 Hexanes:EtOAc); [α]D
21 = -
23.7 (c = 0.01 g/mL); HPLC analysis: Chiralpak IA column, 90:10 hexanes/iso-propanol, 1.0 
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mL/min. Major: 6.4 min, minor: 5.8 min. 1HNMR: (400 MHz, Chloroform-d) δ 7.40 – 7.29 (m, 
3H), 7.22 – 7.16 (m, 2H), 6.70 (d, J = 1.6 Hz, 1H), 5.87 (d, J = 8.8 Hz, 1H), 4.60 (dd, J = 8.2, 4.4 
Hz, 1H), 4.28 (s, 2H), 3.65 (s, 3H), 3.38 (t, J = 3.7 Hz, 1H), 2.30 (dd, J = 7.2, 2.9 Hz, 2H), 1.99 – 
1.91 (m, 1H), 1.69 – 1.60 (m, 1H), 1.38 – 1.16 (m, 9H), 0.92 – 0.85 (m, 4H). 13CNMR: (101 
MHz, Chloroform-d) δ 173.70, 161.51, 144.08, 136.18, 128.99, 128.19, 127.16, 122.89, 121.22, 
110.47, 103.75, 102.63, 92.89, 80.85, 57.52, 55.30, 51.53, 41.78, 36.39, 35.60, 33.30, 32.01, 
30.77, 28.49, 27.00, 22.55, 14.06. IR (ATR, neat) 2952, 2927, 2856, 2192, 1731, 1673, 1591, 
1411, 1204, 1151 cm-1; LRMS (ESI + APCI) m/z [M+H] calcd 353.2, found 353.3 
 
methyl 3-(1-benzyl-3-cyano-1,4-dihydropyridin-4-yl)-3-
cyclopropylpropanoate (44): Pale yellow oil. 31% yield, 3:1 rr, 3:1 dr, 85% ee. Rf = 0.4 (4:1 
Hexanes:EtOAc); [α]D
21 = -60.0 (c = 0.01 g/mL); HPLC analysis: Chiralpak IA column, 90:10 
hexanes/iso-propanol, 1.0 mL/min. Major: 14.3 min, minor: 16.2 min. 1HNMR: (400 MHz, 
Chloroform-d) δ 7.35 (d, J = 7.1 Hz, 4H), 7.21 – 7.17 (m, 2H), 6.71 (d, J = 1.6 Hz, 1H), 5.91 (d, 
J = 10.2 Hz, 1H), 4.62 (dd, J = 8.1, 4.6 Hz, 1H), 4.29 (s, 3H), 3.66 – 3.64 (m, 3H), 3.46 – 3.41 
(m, 1H), 2.42 (dd, J = 24.9, 7.4 Hz, 3H), 1.24 – 1.17 (m, 1H), 0.94 – 0.82 (m, 2H), 0.50 – 0.47 
(m, 1H), 0.45 – 0.41 (m, 1H), 0.32 (dt, J = 9.0, 4.5 Hz, 1H), 0.08 (tt, J = 9.5, 4.6 Hz, 2H). 
13CNMR: (101 MHz; CDCl3): δ 173.59, 148.79, 144.05, 136.16, 128.98, 127.19, 123.45, 
121.54, 110.13, 81.01, 59.04, 47.88, 45.35, 37.85, 36.50, 34.53, 13.18, 11.62, 4.58, 3.57. IR 
(ATR, neat) 3064, 3002, 2923, 2851, 2192, 1673, 1591, 1437, 1414, 1245, 1180 cm-1 LRMS 
(ESI + APCI) m/z [M+H] calcd 323.2, found 323.2 
 
methyl 3-(1-benzyl-3-cyano-1,4-dihydropyridin-4-yl)-5-
methylhexanoate (45): Pale yellow oil. 52% yield, 3:1 rr, 2:1 dr, 58% ee. Rf = 0.2 (4:1 
Hexanes:EtOAc); [α]D
21 = -18.9 (c = 0.010 g/mL); HPLC analysis: Chiralpak IE column, 90:10 
hexanes/iso-propanol, 1.0 mL/min. Major: 38.1 min, minor: 33.8 min. 1HNMR: (400 MHz, 
Chloroform-d) δ 7.35 (dq, J = 11.9, 6.6, 5.2 Hz, 4H), 7.21 – 7.19 (m, 1H), 6.71 (d, J = 1.6 Hz, 
1H), 5.88 (d, J = 8.2 Hz, 1H), 4.60 (dd, J = 8.1, 4.3 Hz, 1H), 4.28 (s, 2H), 3.66 (d, J = 6.9 Hz, 
3H), 3.38 (s, 1H), 2.28 (t, J = 6.9 Hz, 2H), 1.60 (ddd, J = 19.8, 14.2, 6.6 Hz, 2H), 1.49 – 1.43 (m, 
1H), 1.18 – 1.07 (m, 1H), 0.91 (d, J = 6.5 Hz, 6H). 13CNMR: (101 MHz, Chloroform-d) δ 
173.60, 161.51, 148.80, 136.20, 129.59, 129.42, 128.99, 128.20, 127.22, 127.14, 122.98, 121.13, 
103.61, 102.61, 92.90, 57.53, 55.31, 51.53, 40.04, 39.21, 36.33, 35.74, 25.19, 23.30, 22.10. IR 
(ATR, neat) 2926, 2867, 2193, 1733, 1674, 1593, 1454, 1206, 1194, 1152 cm-1 LRMS (ESI + 





methylpentanoate (46): Pale yellow oil. 54% yield, 5:1 rr, 3:1 dr, 42% ee. Rf = 0.2 (4:1 
Hexanes:EtOAc); [α]D
21 = 0.5699 (c = 0.011 g/mL); HPLC analysis: Chiralpak IA column, 
90:10 hexanes/iso-propanol, 1.0 mL/min. Major: 14.6 min, minor: 10.2 min. 1HNMR: (500 
MHz, Chloroform-d) δ 7.46 – 7.32 (m, 8H), 7.23 (q, J = 8.2, 7.0 Hz, 4H), 6.67 (d, J = 1.5 Hz, 
1H), 5.91 – 5.85 (m, 1H), 4.59 (dd, J = 8.2, 4.3 Hz, 1H), 4.31 (d, J = 3.9 Hz, 3H), 3.68 (s, 3H), 
3.54 (t, J = 3.7 Hz, 1H), 3.36 (d, J = 5.9 Hz, 1H), 2.60 (dd, J = 15.8, 5.8 Hz, 1H), 2.37 – 2.31 (m, 
1H), 1.94 (qd, J = 7.1, 3.2 Hz, 1H), 1.77 – 1.69 (m, 2H), 0.96 (dd, J = 6.6, 5.1 Hz, 8H). 
13CNMR: (126 MHz, Chloroform-d) δ 174.40, 143.73, 136.06, 129.61, 129.03, 128.24, 127.92, 
127.30, 120.88, 102.91, 82.59, 57.44, 51.56, 47.66, 35.24, 34.24, 28.80, 20.59. IR (ATR, neat) 
2958, 2192, 1732, 1672, 1627, 1592, 1367, 1413 1181, 1118, 703 cm-1 LRMS (ESI + APCI) m/z 
[M+H] calcd 325.4, found 325.1 
 
methyl (R)-3-((S)-1-benzyl-3-cyano-1,4-dihydropyridin-4-yl)-3-
phenylpropanoate (47): Pale yellow oil. 40.5 mg, 57% yield, 8:1 rr, 1:1 dr, 24% ee. Rf = 0.2 
(4:1 Hexanes:EtOAc); [α]D
21 = -20.0 (c = 0.017 g/mL); HPLC analysis: Chiralpak IE column, 
70:30 hexanes/iso-propanol, 1.0 mL/min. Major: 14.3 min, minor: 16.2 min. 1HNMR: (500 
MHz, Chloroform-d) δ 7.42 – 7.29 (m, 12H), 7.28 – 7.24 (m, 3H), 7.21 (d, J = 7.2 Hz, 2H), 7.09 
(d, J = 6.9 Hz, 2H), 6.82 (dd, J = 6.5, 2.8 Hz, 2H), 6.68 (d, J = 1.5 Hz, 1H), 6.48 (d, J = 1.5 Hz, 
1H), 5.88 (d, J = 8.1 Hz, 1H), 5.78 (d, J = 8.1 Hz, 1H), 4.70 (dd, J = 8.1, 4.7 Hz, 1H), 4.54 (dd, J 
= 8.1, 4.5 Hz, 1H), 4.26 (s, 2H), 4.12 (s, 2H), 3.61 (dd, J = 6.4, 3.8 Hz, 1H), 3.59 (s, 3H), 3.59 (s, 
3H), 3.55 (t, J = 4.1 Hz, 1H), 3.43 – 3.35 (m, 2H), 3.00 – 2.74 (m, 4H). 13CNMR: (126 MHz, 
Chloroform-d) δ 172.91, 172.35, 144.05, 143.71, 139.89, 139.52, 129.76, 129.56, 129.17, 
129.06, 128.93, 128.35, 128.26, 128.24, 127.97, 127.95, 127.17, 126.88, 126.80, 121.28, 120.99, 
81.11, 57.47, 57.21, 51.70, 51.66, 47.68, 40.22, 39.14, 35.88, 34.92. IR (ATR, neat) 3029, 2949, 
2910, 2191, 1733, 1673, 1591, 1453, 1413, 1184, 1160, 740, 702 cm-1 LRMS (ESI) m/z [M+H] 





phenylpent-4-enoate (48): Pale yellow oil. 38% yield, 5:1 rr, 1:1 dr, 24% ee. Rf = 0.2 (4:1 
Hexanes:EtOAc); [α]D
21 = -91.8 (c = 0.006 g/mL); HPLC analysis: Chiralpak IE column, 80:20 
hexanes/iso-propanol, 1.0 mL/min. Major: 36.4 min, minor: 32.9 min. 1HNMR: (500 MHz, 
Chloroform-d) δ 7.36 (dd, J = 12.3, 7.8 Hz, 4H), 7.34 – 7.30 (m, 4H), 7.26 (dd, J = 7.6, 3.4 Hz, 
2H), 7.21 (d, J = 7.8 Hz, 1H), 7.09 (dd, J = 7.5, 2.7 Hz, 2H), 6.68 (t, J = 1.8 Hz, 1H), 6.18 (dd, J 
= 15.8, 9.4 Hz, 1H), 5.94 (dt, J = 8.2, 2.2 Hz, 1H), 4.77 – 4.68 (m, 1H), 4.27 (s, 2H), 3.66 (s, 
3H), 3.59 (s, 1H), 3.50 (dt, J = 12.8, 4.1 Hz, 1H), 2.90 (dt, J = 10.2, 4.7 Hz, 1H), 2.84 – 2.73 (m, 
1H), 2.60 – 2.49 (m, 1H).13CNMR: (126 MHz, Chloroform-d) δ 172.46, 143.83, 133.09, 132.32, 
129.95, 129.08, 129.02, 128.57, 128.28, 127.36, 127.19, 127.05, 126.50, 103.25, 102.21, 57.53, 
51.74, 47.70, 40.23, 39.16, 38.78, 38.45, 35.91. IR (ATR, neat) 3026, 2954, 2923, 2856, 2191, 
1732, 1672, 1590, 1412, 1182, 747, 701 cm-1 LRMS (ESI) m/z [M+H] calcd 385.2, found 385. 
 
methyl 3-(5-cyano-1-(4-methoxybenzyl)-1,2,3,4-tetrahydropyridin-
4-yl)-5-phenylpentanoate: Palladium hydroxide (XX mg, XX mmol) was added to a vial 
containing dihydropyridine 3i (42.3 mg, 0.1 mmol) and methanol (2 mL) at room temperature 
under argon. The vial was then placed under vacuum and back-filled with Argon two times. 
After removal of the argon atmosphere a third time with vacuum, a hydrogen balloon was placed 
in the vial and the reaction stirred was stirred for 12 h. After this time, celite is added to the 
reaction mixture, and the solids were removed by filtration through celite to give 37.4 mg (88%, 
3:1 dr, 86% ee) of a yellow oil. Rf = 0.2 (4:1 Hexanes:EtOAc); [α]D
21 = -35.2 (c = 0.125 g/mL); 
HPLC analysis: Chiralpak IB column, 85:15 hexanes/iso-propanol, 1.0 mL/min. Major: 31.2 
min, minor: 29.0 min. 1HNMR: (500 MHz, Chloroform-d) δ 7.32 – 7.27 (m, 2H), 7.23 – 7.17 
(m, 3H), 7.14 – 7.09 (m, 2H), 6.98 (dd, J = 11.3, 1.2 Hz, 1H), 6.93 – 6.87 (m, 2H), 4.17 (d, J = 
7.4 Hz, 2H), 3.83 (s, 3H), 3.71 (s, 3H), 3.01 (dt, J = 12.3, 5.5 Hz, 2H), 2.74 – 2.63 (m, 2H), 2.57 
(dd, J = 15.2, 6.3 Hz, 1H), 2.47 (d, J = 7.9 Hz, 1H), 2.34 – 2.21 (m, 1H). 13CNMR: (101 MHz, 
Chloroform-d) δ 173.41, 159.47, 142.24, 128.91, 128.38, 125.84, 122.88, 114.29, 58.95, 55.33, 
51.65, 43.85, 38.51, 37.83, 36.73, 35.86, 34.48, 33.98, 29.70, 22.53. IR (ATR, neat) 2927, 2855, 






yl)-5-phenylpentanoate: A solution of dihydropyridine 3i (44.3 mg, 0.11 mmol) in CH2Cl2 (2 
mL) was cooled to -10 ̊C, and triethylsilane (340 uL, 20 equiv) was added along with 
trifluoracetic acid (204 uL, 25 equiv). This mixture was then allowed to stir while warming to 
room temperature. After 12 h, volatiles were removed under reduced pressure. The resulting 
crude oil was purified by column chromatography (DCM/MeOH) to give 10 (51%, 22.8 mg, 
0.054 mmol, 3:1 dr, 84% ee) as an off-white solid. Rf = 0.2 (98:2 DCM:MeOH); [α]D
21 = -37.8 (c 
= 0.008 g/mL); HPLC analysis: Chiralpak IB column, 85:15 hexanes/iso-propanol, 1.0 mL/min. 
Major: 10.6 min, minor: 11.6 min. 1HNMR: (500 MHz, Chloroform-d) δ 7.34 – 7.26 (m, 4H), 
7.22 (d, J = 7.3 Hz, 1H), 7.18 (d, J = 7.2 Hz, 2H), 6.96 (d, J = 8.4 Hz, 2H), 4.11 (dd, J = 64.4, 
13.0 Hz, 2H), 3.85 (s, 3H), 3.70 (s, 3H), 3.57 (d, J = 11.6 Hz, 1H), 3.48 – 3.38 (m, 1H), 2.80 – 
2.66 (m, 2H), 2.60 (dt, J = 15.2, 7.5 Hz, 3H), 2.44 – 2.31 (m, 1H), 2.25 (dd, J = 15.2, 9.9 Hz, 
1H), 1.89 (dd, J = 26.0, 10.7 Hz, 3H), 1.81 – 1.71 (m, 1H), 1.42 (dtd, J = 14.4, 9.5, 5.2 Hz, 1H). 
13CNMR: (126 MHz, Chloroform-d) δ 172.46, 140.59, 128.60, 128.25, 126.26, 119.17, 116.76, 
114.90, 60.42, 55.43, 51.92, 51.70, 51.51, 39.71, 36.06, 35.90, 33.72, 30.50, 29.07, 21.82. IR 
(ATR, neat) 2925, 1734, 1673, 1612, 1514, 1454, 1251, 1180, 1032, 830 cm-1 LRMS (ESI) m/z 
















































































































Single crystal X-ray diffraction.1 Data for all compounds was collected on an Agilent 
SuperNova diffractometer using mirror-monochromated Cu K. Data collection, 
integration, scaling (ABSPACK) and absorption correction (face-indexed Gaussian 
integration2 or numeric analytical methods3) were performed in CrysAlisPro.4 Structure 
solution was performed using ShelXT.5 Subsequent refinement was performed by full-
matrix least-squares on F2 in ShelXL.Error! Bookmark not defined. Olex26 was used for 
viewing and to prepare CIF files. PLATON7 was used for Bijvoet difference analysis of 
absolute structure (further details within). ORTEP graphics were prepared in CrystalMaker.8 
Thermal ellipsoids are rendered at the 50% probability level.  
 
A single crystal of Darrin1 was grown from a sample of 94% enantiomeric purity as determined 
by chiral HPLC. A dichloromethan solution was diluted with pentane by vapor diffusion to 
afford apque, colorless blades. Part of a crystal (.20 x .05 x .05 mm) was separated carefully, 
mounted with STP oil treatment, and cooled to 100 K on the diffractometer. A full sphere of 
data were collected to 0.800 Å resolution. 43306 reflections were collected (4462 unique, 
4366 observed) with R(int) 4.2% and R(sigma) 2.0% after Gaussian absorption and beam 
profile correction (Tmin .910, Tmax .977).  
 
The space group was assigned as P212121 based on the systematic absences. The structure solved 
routinely in ShelXT with 1 molecule in the asymmetric unit. All non-H atoms were located 
in the initial solution and refined anisotropically with no restraints. C-H hydrogens were 
placed in calculated positions and refined with riding coordinates and ADPs.  
 
The final refinement (462 data, 0 restraints, 282 parameters) converged with R1 (Fo > 4σ(Fo)) = 
2.9%, wR2 = 7.4%, S = 1.05. The largest Fourier features were 0.16 and -0.15 e
- A-3.  
 
1 Single crystal X-ray diffraction was performed at the Shared Materials Characterization Laboratory at Columbia 
University. Use of the SMCL was made possible by funding from Columbia University. 
2 Blanc, E.; Schwarzenbach, D.; Flack, H. D. J. Appl. Cryst. 24 (1991), 1035-1041. 
3 Clark. R. C.; Reid, J. S. Acta Cryst. A51 (1995), 887-897. 
4 Version 1.171.37.35 (2014). Oxford Diffraction /Agilent Technologies UK Ltd, Yarnton, England. 
5 Sheldrick, G. M. Acta Cryst. A71 (2015), 3-8. 
6 Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. Cryst. 42 (2009), 339-
341. 
7 Spek, A. Acta Cryst. D65 (2009), 148-155. 




A crystal with molecular formula C26H32N2O3 is a reasonable target for absolute structure 
determination using Cu K radiation.9 The Flack x parameter was 0.07(6) by the Parsons 
selected quotients method implemented in ShelXL. For confirmation of the absolute 
structure, the data set was analyzed by the probabilistic approach of Hooft, Straver, and 
Spek10 as implemented in PLATON. Errors were assumed to be Gaussian; a normal 
probabilities plot was linear with correlation coefficient 0.999 and slope 0.956. Using an 
outlier criterion of 79.66 and sigma criterion of 0.25, 404 Bijvoet pairs were selected for 
analysis. The Hooft y parameter was 0.06(6) using these parameters. The probability of a 
racemic twin, P3(rac-twin), was calculated as 4 x 10-14 and the probability of an incorrect 
absolute structure, P3(false), was 4 x 10-63. Therefore, we state with high confidence that the 
absolute structure is correctly assigned. 
 







Space group P212121 
a (Å) 6.27180(10) 
b (Å) 14.71860(10) 
c (Å) 24.2813(2) 
α (°) 90 
β (°) 90 
γ (°) 90 
V (Å3) 2241.46(4) 
Z 4 
ρcalc (g cm-3) 1.246 
 
 
T (K) 100 
λ (Å) 1.54184 
2θmin, 2θmax 7, 146 
Nref 43306 
R(int), R(σ) .0424, .0200 
μ(mm-1) 0.645 
Size (mm) .20 x .05 x .05 





9 Parsons, S.; Flack, H. D.; Wagner, T. Acta Cryst. B69 (2013), 249-259. 








Peak, hole (e- 
Å-3) 
0.16, -0.15 
Hooft y 0.06(6) 
 
Table 1 Crystal data and structure refinement for bcorr_a.  
Identification code  bcorr_a  
Empirical formula  C26H32N2O3  
Formula weight  420.53  
Temperature/K  100.01(10)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  6.27180(10)  
b/Å  14.71860(10)  
c/Å  24.2813(2)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  2241.46(4)  
Z  4  
ρcalcg/cm
3  1.246  
μ/mm-1  0.645  
F(000)  904.0  
Crystal size/mm3  0.196 × 0.049 × 0.048  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.022 to 145.98  
Index ranges  -7 ≤ h ≤ 7, -18 ≤ k ≤ 18, -29 ≤ l ≤ 30  
Reflections collected  43306  
Independent reflections  4462 [Rint = 0.0424, Rsigma = 0.0200]  
Data/restraints/parameters  4462/0/282  
Goodness-of-fit on F2  1.045  
Final R indexes [I>=2σ (I)]  R1 = 0.0288, wR2 = 0.0737  
Final R indexes [all data]  R1 = 0.0296, wR2 = 0.0743  
Largest diff. peak/hole / e Å-3  0.16/-0.15  





Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for bcorr_a. Ueq is defined as 1/3 of of the trace of the orthogonalised 
UIJ tensor. 
Atom x y z U(eq) 
N1 119(2) 6276.2(9) 4025.4(5) 14.3(3) 
C2 1459(3) 5863.1(10) 3599.9(6) 14.5(3) 
C3 1802(3) 4848(1) 3725.0(6) 13.8(3) 
C4 -340(3) 4333.5(10) 3765.3(6) 12.8(3) 
C5 -1718(3) 4828.5(11) 4189.4(7) 15.3(3) 
C6 -1977(3) 5828.5(11) 4041.4(7) 16.0(3) 
C7 -160(3) 7255.8(11) 3914.0(7) 16.4(3) 
C8 1881(3) 7787.7(10) 3960.5(7) 15.4(3) 
C9 2978(3) 8097.8(11) 3497.2(7) 19.8(3) 
C10 4843(3) 8597.6(12) 3544.5(7) 21.7(3) 
C11 5639(3) 8806.5(10) 4066.3(7) 17.7(3) 
C12 4574(3) 8509.4(11) 4535.4(7) 16.5(3) 
C13 2721(3) 7999.8(10) 4476.1(6) 15.2(3) 
O14 7478(2) 9307.6(9) 4077.0(6) 26.6(3) 
C15 8326(3) 9528.5(14) 4604.8(9) 31.0(4) 
C16 3128(3) 4455.1(11) 3285.4(7) 16.9(3) 
N17 4098(3) 4146.8(10) 2931.3(7) 24.8(3) 
C18 -48(3) 3308.4(10) 3871.2(6) 12.9(3) 
C19 699(3) 3095.3(11) 4462.0(6) 15.1(3) 
C20 1311(3) 2110.6(11) 4515.1(6) 15.5(3) 
O21 509(2) 1566.1(9) 4822.5(5) 24.8(3) 
O22 2912(2) 1902.1(8) 4168.6(5) 20.4(3) 
C23 3544(3) 961.9(12) 4143.5(7) 23.6(4) 
C24 -2091(3) 2778.0(11) 3727.9(7) 16.9(3) 
C25 -2258(3) 2554.3(12) 3110.6(7) 21.1(4) 
C26 -737(3) 1811.4(12) 2941.8(7) 17.9(3) 
C27 -1243(3) 906.5(13) 3052.4(7) 21.1(4) 
C28 167(3) 208.4(12) 2929.6(8) 26.2(4) 
C29 2117(3) 402.7(14) 2690.4(8) 27.7(4) 
C30 2639(3) 1295.0(15) 2570.9(7) 27.5(4) 




Table 3 Anisotropic Displacement Parameters (Å2×103) for bcorr_a. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
N1 15.8(6) 10.9(6) 16.2(6) -2.7(5) 0.6(5) 1.1(5) 
C2 17.4(8) 11.6(7) 14.5(7) -0.5(6) 1.5(6) 0.1(6) 
C3 13.3(7) 12.9(7) 15.3(7) -0.7(6) 1.7(6) 1.1(6) 
C4 13.5(7) 13.3(7) 11.7(7) -0.9(5) -0.6(6) 0.5(6) 
C5 15.1(7) 15.4(7) 15.5(7) -1.2(6) 2.0(6) 0.1(6) 
C6 14.5(7) 15.1(7) 18.3(7) -4.3(6) -0.3(6) 2.5(6) 
C7 18.1(8) 12.1(7) 18.9(7) -1.8(6) -3.1(6) 3.9(6) 
C8 18.6(8) 10.9(7) 16.6(7) -0.5(6) -1.2(6) 3.0(6) 
C9 27.4(8) 16.7(8) 15.4(7) 1.3(6) -0.9(7) 4.4(7) 
C10 28.0(9) 18.1(8) 19.0(8) 5.6(6) 6.8(7) 2.9(7) 
C11 16.8(8) 10.9(7) 25.5(8) 1.4(6) 2.7(7) -0.2(6) 
C12 19.4(8) 12.7(7) 17.3(7) -0.7(6) -0.6(6) 3.0(6) 
C13 19.3(7) 12.1(7) 14.4(7) 1.0(6) 2.5(6) 1.4(6) 
O14 22.6(6) 20.4(6) 36.9(7) 2.9(5) 6.1(6) -5.2(5) 
C15 21.1(9) 25.7(10) 46.1(12) -7.9(8) -1.0(8) -5.2(7) 
C16 16.9(7) 12.3(7) 21.5(8) 2.6(6) 2.8(7) 0.5(6) 
N17 24.5(8) 18.7(7) 31.3(8) 1.2(6) 13.0(7) 2.0(6) 
C18 14.6(7) 11.5(7) 12.6(7) -0.8(5) 0.5(6) 0.1(6) 
C19 18.4(7) 14.1(7) 12.8(7) -0.4(6) 0.8(6) 0.5(6) 
C20 17.5(7) 17.0(8) 12.0(7) -0.2(6) -1.5(6) 0.8(6) 
O21 29.1(7) 19.1(6) 26.1(6) 4.9(5) 8.4(5) 0.9(5) 
O22 23.3(6) 17.1(6) 20.7(6) 2.7(4) 6.3(5) 4.6(5) 
C23 30.3(10) 19.7(8) 21.0(8) 0.9(7) 3.4(7) 10.8(7) 
C24 14.1(7) 16.8(7) 19.8(8) -3.5(6) -0.1(6) -0.9(6) 
C25 22.0(8) 18.3(8) 23.0(8) -6.5(6) -9.3(7) 4.1(7) 
C26 20.5(8) 19.5(8) 13.7(7) -5.6(6) -4.9(6) 1.8(7) 
C27 21.3(8) 21.9(9) 20.1(8) -3.3(7) 1.4(7) 1.0(7) 
C28 36.3(10) 21.0(8) 21.3(8) -3.0(7) -0.3(8) 7.9(8) 
C29 28.1(9) 35.8(10) 19.3(8) -10.1(7) -5.3(7) 13.0(8) 
C30 18.5(8) 48.3(11) 15.7(8) -10.9(8) -0.5(6) -1.0(8) 





Table 4 Bond Lengths for bcorr_a. 
Atom Atom Length/Å   Atom Atom Length/Å 
N1 C2 1.464(2)   O14 C15 1.425(3) 
N1 C6 1.471(2)   C16 N17 1.147(2) 
N1 C7 1.4775(19)   C18 C19 1.541(2) 
C2 C3 1.540(2)   C18 C24 1.540(2) 
C3 C4 1.546(2)   C19 C20 1.505(2) 
C3 C16 1.472(2)   C20 O21 1.205(2) 
C4 C5 1.529(2)   C20 O22 1.345(2) 
C4 C18 1.541(2)   O22 C23 1.441(2) 
C5 C6 1.524(2)   C24 C25 1.538(2) 
C7 C8 1.505(2)   C25 C26 1.508(2) 
C8 C9 1.395(2)   C26 C27 1.395(3) 
C8 C13 1.394(2)   C26 C31 1.392(3) 
C9 C10 1.387(3)   C27 C28 1.388(3) 
C10 C11 1.396(3)   C28 C29 1.384(3) 
C11 C12 1.391(2)   C29 C30 1.384(3) 
C11 O14 1.369(2)   C30 C31 1.395(3) 
C12 C13 1.391(2)         
  
Table 5 Bond Angles for bcorr_a. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C2 N1 C6 110.21(12)   C12 C13 C8 121.98(15) 
C2 N1 C7 110.13(13)   C11 O14 C15 117.03(14) 
C6 N1 C7 109.63(13)   N17 C16 C3 177.57(19) 
N1 C2 C3 110.12(13)   C19 C18 C4 112.99(12) 
C2 C3 C4 111.48(13)   C24 C18 C4 111.08(13) 
C16 C3 C2 108.50(13)   C24 C18 C19 111.09(13) 
C16 C3 C4 110.16(13)   C20 C19 C18 110.68(13) 
C5 C4 C3 107.48(12)   O21 C20 C19 125.94(15) 
C5 C4 C18 114.91(13)   O21 C20 O22 123.17(15) 
C18 C4 C3 112.76(13)   O22 C20 C19 110.89(13) 
C6 C5 C4 111.21(13)   C20 O22 C23 116.80(13) 
N1 C6 C5 110.10(13)   C25 C24 C18 112.67(14) 
N1 C7 C8 113.15(13)   C26 C25 C24 112.14(14) 
C9 C8 C7 121.95(15)   C27 C26 C25 119.71(16) 
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C13 C8 C7 120.36(15)   C31 C26 C25 122.27(17) 
C13 C8 C9 117.68(15)   C31 C26 C27 117.97(16) 
C10 C9 C8 121.52(16)   C28 C27 C26 121.33(18) 
C9 C10 C11 119.58(15)   C29 C28 C27 120.02(18) 
C12 C11 C10 120.15(15)   C28 C29 C30 119.54(17) 
O14 C11 C10 115.91(16)   C29 C30 C31 120.31(18) 
O14 C11 C12 123.94(16)   C26 C31 C30 120.82(18) 
C13 C12 C11 119.08(15)           
  
Table 6 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) 
for bcorr_a. 
Atom x y z U(eq) 
H2A 2853.28 6177.35 3586.59 17 
H2B 765.53 5931.28 3235.89 17 
H3 2574.74 4789.21 4083.55 17 
H4 -1066.41 4397.43 3400.7 15 
H5A -3139.3 4537.51 4207.03 18 
H5B -1049.18 4776.88 4557.38 18 
H6A -2676.27 5883.14 3677.39 19 
H6B -2894.38 6130.8 4317.98 19 
H7A -1212.7 7506.56 4177.13 20 
H7B -745.44 7332.95 3538.2 20 
H9 2434.1 7963.51 3141.25 24 
H10 5574.35 8796.57 3223.86 26 
H12 5105.5 8652.52 4891.38 20 
H13 2005.72 7789.92 4796.73 18 
H15A 7284.82 9890.72 4810.51 46 
H15B 9643.65 9878.76 4559.29 46 
H15C 8634.51 8968 4807.61 46 
H18 1094.73 3091.49 3615.82 15 
H19A 1938.99 3482.11 4555 18 
H19B -461.77 3236.03 4724.84 18 
H23A 3641.51 715.67 4517.63 35 
H23B 4935.95 913.9 3962.51 35 
H23C 2484.05 616.76 3933.33 35 
H24A -2115.35 2204.92 3941.27 20 
H24B -3347.29 3141.71 3838.83 20 
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H25A -3735.01 2362.61 3025.43 25 
H25B -1948.66 3108.38 2893.79 25 
H27 -2580.6 765.33 3215.07 25 
H28 -207.15 -402.92 3009.68 31 
H29 3090.74 -73.01 2608.75 33 
H30 3968.13 1431.03 2402.39 33 
H31 1599.86 2605.42 2614.37 28 
Experimental  
Single crystals of C26H32N2O3 [bcorr_a] were []. A suitable crystal was selected and [] on a 
SuperNova, Dual, Cu at zero, EosS2 diffractometer. The crystal was kept at 100.01(10) K 
during data collection. Using Olex2 [1], the structure was solved with the ShelXT [2] 
structure solution program using Intrinsic Phasing and refined with the ShelXL [3] 
refinement package using Least Squares minimisation. 
1. Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, H. (2009), 
J. Appl. Cryst. 42, 339-341. 
2. Sheldrick, G.M. (2015). Acta Cryst. A71, 3-8. 
3. Sheldrick, G.M. (2015). Acta Cryst. C71, 3-8. 
Crystal structure determination of [bcorr_a]  
Crystal Data for C26H32N2O3 (M =420.53 g/mol): orthorhombic, space group P212121 (no. 19), 
a = 6.27180(10) Å, b = 14.71860(10) Å, c = 24.2813(2) Å, V = 2241.46(4) Å3, Z = 4, T = 
100.01(10) K, μ(CuKα) = 0.645 mm-1, Dcalc = 1.246 g/cm3, 43306 reflections measured 
(7.022° ≤ 2Θ ≤ 145.98°), 4462 unique (Rint = 0.0424, Rsigma = 0.0200) which were used in all 
calculations. The final R1 was 0.0288 (I > 2σ(I)) and wR2 was 0.0743 (all data).  
Refinement model description  
Number of restraints - 0, number of constraints - unknown.  
Details: 
1. Fixed Uiso 
 At 1.2 times of: 
  All C(H) groups, All C(H,H) groups 
 At 1.5 times of: 
  All C(H,H,H) groups 
2.a Ternary CH refined with riding coordinates: 
 C3(H3), C4(H4), C18(H18) 
2.b Secondary CH2 refined with riding coordinates: 




 H24B), C25(H25A,H25B) 
2.c Aromatic/amide H refined with riding coordinates: 
 C9(H9), C10(H10), C12(H12), C13(H13), C27(H27), C28(H28), C29(H29), C30(H30), 
 C31(H31) 
2.d Idealised Me refined as rotating group: 











 3,4,5-trimethoxybenzenediazonium tetrafluoroborate:  A 250 mL RB 
flask containing 3,4,5-trimethoxyaniline (9.09 g, 49.6 mmol) dissolved in 150 mL THF (0.3 M) 
was cooled to 10 ̊C and HBF4 48 wt.% in water (17.7 mL, 135 mmol, 2.7 equiv) was added 
dropwise over 15-20 minutes. t-butyl nitrite (7.5 mL, 63.1 mmol, 1.3 equiv) was then added 
drop-wise over 25 minutes, and the mixture was stirred for 15 minutes. After this time, the 
precipitate was collected by vacuum filtration, rinsed generously with Et2O, and dried in vacuo 
to give 13.03 g (93%) of a tan/pale yellow precipitate used without further purification. Spectral 
data matches those previously reported.1 1H NMR (300 MHz; DMSO-d6): δ 8.15 (s, 2H), 4.00 (s, 
3H), 3.87 (s, 6H). 
(3,4,5-trimethoxyphenyl)hydrazine: To a solution of tin(II)chloride 
dihydrate ( 3.0 g, 13.3 mmol, 2.5 equiv) in 6 M HCl (20 mL) at 10 ̊C (ice/brine) was added 
3,4,5-trimethoxybenzenediazonium tetrafluoroborate (1.5 g, 5.3 mmol, 1 equiv) portion-wise 
over 20 min. After stirring for 2 hours at the same temperature, 25 mL DCM was added along 
with 12 M KOH (20 mL), keeping the temperature below 0 ̊C. At this point, the foamy off-white 
solution became clear and the layers were separated. The aqueous mixture was then extracted 
again with DCM (1 x 25 mL). The combined organic extract was then dried (Na2SO4) and 
concentrated in vacuo to 1/3 the volume (~15 mL). The dry DCM/hydrazine solution was then 
used immediately in the next step without further purification. 
2-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5H-pyrrolo[2,1-
c][1,2,4]triazol-2-ium tetrafluoroborate: Prepared according to a literature procedure2, with 
minor modifications. To a flame-dried flask under Ar was added 0.38 mL 2-pyrolidinone along 
with 10 mL anhydrous DCM. Trimethyloxonium tetrafluoroborate (743 mg, 5.0 mmol, 1 equiv) 
was then added quickly, in one portion, and the mixture was stirred until homogenous (~3 hr). 
After this time, the dried crude solution of (3,4,5-trimethoxyphenyl)hydrazine (5.3 mmol in ~15 
mL DCM) was added and the mixture stirred for an additional 8 hr. The resultant deep red 
solution was concentrated in vacuo until most of the DCM was removed (~2 mL total volume) 
and diluted with EtOAc (25 mL) causing a precipitate to form. The pink/orange precipitate was 
then collected by vacuum filtration and dried in vacuo (30 min) to give 505 mg (1.43 mmol, 
29%) of the corresponding hydrazinium.3 The crude powder was then diluted with 10 mL MeCN 
and 1 mL trimethylorthoformate (9.1 mmol, 6.5 equiv), and the mixture was heated to reflux for 
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12 hr. After this time, the reaction was allowed to cool to rt and concentrated in vacuo. The crude 
residue was dissolved in a minimum amount of DCM (~20 mL) and the title compound 
precipitated upon addition of 5 mL EtOAc. The precipitate was then collected by vacuum 
filtration, and rinsed with Et2O to give 434 mg (1.2 mmol, 24% overall yield) of pure azolium as 
a colorless powder. 1H-NMR (400 MHz; acetone-d6): δ 10.25 (s, 1H), 7.24 (s, 2H), 4.63 (t, J = 
7.6 Hz, 2H), 3.93 (s, 6H), 3.81 (s, 3H), 3.56 (t, J = 7.6 Hz, 2H), 2.93 – 3.00 (m, 2H). 13C-NMR 
(101 MHz; acetone-d6): δ 163.4, 154.3, 139.7, 137.8, 98.9, 59.9, 56.0, 47.5, 26.7, 21.5. 19F-NMR 
(101 MHz; acetone-d6): δ -151.58 IR (ATR, neat) 3144, 2946, 1609, 1588, 1473, 1236, 1128 
cm-1.  









 3-(benzo[d][1,3]dioxol-5-yloxy)propane-1,2-diol: Prepared 
according to a literature procedure. A 100 mL round bottom flask was charged with sesamol 
(6.906 g, 50.0 mmol) and dissolved in 30 mL EtOH. To this solution was added a solution of 
NaOH (2.50 g, 62.5 mmol, 1.2 eq.) in 10 mL H2O and the mixture was heated to reflux for 10 
min. After this time, a solution of 3-chloro-1,2-propane diol (5.0 mL, 6.61 g, 60.0 mmol, 1.25 
eq.) in 5 mL EtOH was added and the resulting mixture was allowed to reflux overnight (  ̴8 hr) 
until TLC indicated complete reaction. After this time, solution was cooled to rt and volatiles 
were removed in vacuo. The resulting residue was diluted with EtOAc (50 mL) and H2O (50 
mL), and the layers separated. The aqueous layer was extracted with EtOAc (6 x25 mL) and the 
combined organic extracts were dried with MgSO4, filtered, and concentrated in vacuo to give a 
pale orange off-white solid (10.9 g) which was used in the next step without further purification. 
Rf= 0.12 in (3:2 Hexanes:EtOAc); quant., 1H-NMR (400 MHz; (CD3)2CO): δ 6.71 (d, J = 8.4 
Hz, 1H), 6.53 (d, J = 2.8 Hz, 1H), 6.37 (dd, J = 8.4, 2.8 Hz, 1H), 5.91 (s, 2H), 4.11 – 3.87 (m, 
4H), 3.72 – 3.59 (m, 3H) 13C NMR (101 MHz; (CD3)2CO): δ 154.7, 148.3, 141.6, 107.7, 105.7, 
101.1, 97.8, 70.5, 70.4, 63.2. IR (neat) 3320, 2933, 2894, 1487, 1194, 1038, 928 cm-1; LRMS 
(ESI) m/z calcd 212.1, found 212.0 
 
2-(benzo[d][1,3]dioxol-5-yloxy)acetaldehyde: Prepared according to a 
literature procedure.Error! Bookmark not defined. To a vigorously stirred solution of silica gel 
(50 g) in 350 mL CH2Cl2 was added a solution of 6.952 g NaIO4 (32.5 mmol) in 50 mL H2O, 
followed by a solution of 5.305 g 3-(benzo[d][1,3]dioxol-5-yloxy)propane-1,2-diol (25.0 mmol) 
in 50 mL CH2Cl2. The resulting mixture was allowed to stir at rt open to the air for 2 hr until 
TLC completed complete reaction. After this time, the reaction mixture was filtered over a bed 
of silica gel and the silica gel was rinsed with ~1 L of CH2Cl2. The Solvent was then removed in 
vacuo to give 3.63 g (20.5 mmol) 2-(benzo[d][1,3]dioxol-5-yloxy)acetaldehyde as an 
analytically pure white solid. Rf= 0.42 in (3:2 Hexanes:EtOAc); 82 % yield, 1H-NMR (400 
MHz; (CD3)2CO): δ 9.75 (s, 1H), 6.73 (d, J = 8.8 Hz, 1H), 6.57 (d, J = 2.4 Hz, 1H), 6.38 (dd, J = 
8.4, 2.8 Hz, 1H), 5.94 (s, 2H), 4.67 (s, 2H) 13C NMR (101 MHz; (CD3)2CO): δ 198.4, 153.6, 
148.5, 142.3, 107.8, 105.9, 101.3, 97.9, 73.5. IR (neat) 2900, 2832, 1738, 1503, 1488, 1187, 
1037 cm-1; LRMS (ESI) m/z calcd 180.0, found 180.0 
 
 (E)-5-((3-nitroallyl)oxy)benzo[d][1,3]dioxole: To an oven-dried 
round bottom flask was added 3.42 g 2-(benzo[d][1,3]dioxol-5-yloxy)acetaldehyde (19.0 mmol), 
1.5 mL nitromethane (28.0 mmol), and 1:1 THF/t-BuOH (25 mL). This solution was then cooled 
to 0 °C and 426 mg potassium tert-butoxide (3.8 mmol) was added in one portion. The reaction 
was allowed to stir at 0 °C for 15 min then warmed to room temperature and stirred for another 2 
h until TLC indicated complete reaction. After completion, saturated aqueous NH4Cl solution 
(50 mL) was added to quench the reaction and then the aqueous layer was extracted with CH2Cl2 
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(4 x 50 mL). The combined organic extracts were then dried (Na2SO4) and concentrated in 
vacuo. After drying the crude residue under vacuum (4 mm) for 0.5 h, CH2Cl2 (50 mL) was 
added and the solution was cooled to 0 °C. Trifluoroacetic anhydride (3.0 mL, 10.9 mmol) was 
then added followed by the slow dropwise addition of 5.6 mL Et3N (40 mmol). After stirring for 
~15 min at 0 °C the reaction was diluted with H2O (30 mL) and CH2Cl2 (50 mL) and the layers 
separated. The organic layer was then washed with sat. aq. NH4Cl (2 x 30 mL), dried (Na2SO4) 
and concentrated in vacuo to give brown-yellow solid, which was then purified by column 
chromatography (3:1 hexanes:ethyl acetate) to give 2.893 g (13.0 mmol) of (E)-5-((3-
nitroallyl)oxy)benzo[d][1,3]dioxole as a bright yellow solid. Rf= 0.4 in (3:1 Hexanes:EtOAc); 68 
% yield, 1H-NMR (400 MHz; (CD3)2CO): δ 7.47 (dt, J = 13.6, 3.6 Hz, 1H), 7.39 (dt, J = 13.6, 
2.0 Hz, 1H), 6.76 (d, J = 8.4 Hz, 1H), 6.65 (d, J = 2.4 Hz, 1H), 6.47 (dd, J = 8.4, 2.4 Hz, 1H), 
5.95 (s, 2H), 4.11 (dd, J = 3.6, 2.0 Hz, 2H), 13C NMR (101 MHz; (CD3)2CO): δ 153.3, 148.5, 
142.4, 139.7, 137.9, 107.8, 106.0, 101.4, 101.4, 98.0, 64.6 IR (neat) 3439, 3124, 1635, 1435, 
933,  
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